SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Organicell Regenerative Medicine, Inc. – ‘S-1’ on 9/22/22 – ‘JSON’

On:  Thursday, 9/22/22, at 5:28pm ET   ·   Accession #:  1829126-22-17082   ·   File #:  333-267563

Previous ‘S-1’:  ‘S-1/A’ on 3/7/22   ·   Next & Latest:  ‘S-1/A’ on 10/20/22   ·   22 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/22/22  Organicell Regenerative Medi… Inc S-1                   78:13M                                    Empire Filings/FA

Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1         Registration Statement (General Form)               HTML   3.29M 
 2: EX-23.1     Consent of Expert or Counsel                        HTML     20K 
 3: EX-FILING FEES  Exhibit 107                                     HTML     28K 
 9: R1          Cover                                               HTML     48K 
10: R2          Consolidated Balance Sheets (Unaudited)             HTML    127K 
11: R3          Consolidated Balance Sheets (Unaudited)             HTML     29K 
                (Parenthetical)                                                  
12: R4          Consolidated Statements of Operations (Unaudited)   HTML     85K 
13: R5          Consolidated Changes to Stockholders? Deficit       HTML     94K 
14: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    139K 
15: R7          Organization and Description of Business            HTML     31K 
16: R8          Summary of Significant Accounting Policies          HTML    121K 
17: R9          Going Concern                                       HTML     43K 
18: R10         Inventories                                         HTML     40K 
19: R11         Property and Equipment                              HTML     75K 
20: R12         Lease Obligations                                   HTML     83K 
21: R13         Related Party Transactions                          HTML     73K 
22: R14         Notes Payable                                       HTML     76K 
23: R15         Income Taxes                                        HTML     95K 
24: R16         Capital Stock                                       HTML    383K 
25: R17         Warrants                                            HTML    129K 
26: R18         Commitments and Contingencies                       HTML    146K 
27: R19         Liabilities Attributable to Discontinued            HTML     40K 
                Operations                                                       
28: R20         Segment Information                                 HTML     29K 
29: R21         Subsequent Events                                   HTML     36K 
30: R22         Restructuring                                       HTML     37K 
31: R23         Irs Penalties                                       HTML     25K 
32: R24         Summary of Significant Accounting Policies          HTML    168K 
                (Policies)                                                       
33: R25         Inventories (Tables)                                HTML     39K 
34: R26         Property and Equipment (Tables)                     HTML     68K 
35: R27         Lease Obligations (Tables)                          HTML     43K 
36: R28         Income Taxes (Tables)                               HTML     89K 
37: R29         Capital Stock (Tables)                              HTML    161K 
38: R30         Warrants (Tables)                                   HTML     88K 
39: R31         Commitments and Contingencies (Tables)              HTML     33K 
40: R32         Liabilities Attributable to Discontinued            HTML     37K 
                Operations (Tables)                                              
41: R33         Summary of Significant Accounting Policies          HTML    100K 
                (Details Narrative)                                              
42: R34         Going Concern (Details Narrative)                   HTML     41K 
43: R35         Inventories (Details)                               HTML     28K 
44: R36         Property and Equipment (Details)                    HTML     44K 
45: R37         Property and Equipment (Details Narrative)          HTML     28K 
46: R38         Lease Obligations (Details)                         HTML     39K 
47: R39         Lease Obligations (Details 1)                       HTML     32K 
48: R40         Lease Obligations (Details Narrative)               HTML     85K 
49: R41         Related Party Transactions (Details Narrative)      HTML    295K 
50: R42         Notes Payable (Details Narrative)                   HTML    255K 
51: R43         Income Taxes (Details)                              HTML     47K 
52: R44         Income Taxes (Details 1)                            HTML     38K 
53: R45         Income Taxes (Details 2)                            HTML     46K 
54: R46         Income Taxes (Details Narrative)                    HTML     30K 
55: R47         Capital Stock (Details - Minimum pre-Transaction    HTML     38K 
                price per share)                                                 
56: R48         Capital Stock (Details - Debt and/or equity         HTML     33K 
                financings)                                                      
57: R49         Capital Stock (Details - Management and             HTML     41K 
                consultants performance stock plan)                              
58: R50         Capital Stock (Details - unvested equity            HTML     38K 
                instruments outstanding)                                         
59: R51         Capital Stock (Details Narrative)                   HTML   1.46M 
60: R52         Warrants (Details - Warrant Activity)               HTML     57K 
61: R53         Warrants (Details Narrative)                        HTML    100K 
62: R54         Commitments and Contingencies (Details)             HTML     45K 
63: R55         Commitments and Contingencies (Details Narrative)   HTML    102K 
64: R56         Liabilities Attributable to Discontinued            HTML     34K 
                Operations (Details)                                             
65: R57         Segment Information (Details Narrative)             HTML     23K 
66: R58         Subsequent Events (Details Narrative)               HTML     53K 
67: R59         Restructuring (Details Narrative)                   HTML     46K 
68: R60         Capital Stock (Details)                             HTML     38K 
69: R61         Capital Stock (Details 1)                           HTML     33K 
70: R62         Capital Stock (Details 2)                           HTML     41K 
71: R63         Capital Stock (Details 3)                           HTML     38K 
72: R64         Warrants (Details)                                  HTML     56K 
73: R65         Irs Penalties (Details Narrative)                   HTML     25K 
76: XML         IDEA XML File -- Filing Summary                      XML    143K 
74: XML         XBRL Instance -- organicellregen_s1_htm              XML   2.95M 
75: EXCEL       IDEA Workbook of Financial Reports                  XLSX    336K 
 5: EX-101.CAL  XBRL Calculations -- bpsr-20220731_cal               XML    172K 
 6: EX-101.DEF  XBRL Definitions -- bpsr-20220731_def                XML    778K 
 7: EX-101.LAB  XBRL Labels -- bpsr-20220731_lab                     XML   1.17M 
 8: EX-101.PRE  XBRL Presentations -- bpsr-20220731_pre              XML   1.08M 
 4: EX-101.SCH  XBRL Schema -- bpsr-20220731                         XSD    226K 
77: JSON        XBRL Instance as JSON Data -- MetaLinks              410±   571K 
78: ZIP         XBRL Zipped Folder -- 0001829126-22-017082-xbrl      Zip    640K 


‘JSON’   —   XBRL Instance as JSON Data — MetaLinks


This File is an XBRL Instance as JavaScript Object Notation (JSON) Data.



{
"instance":  {
    "organicellregen_s1.htm":  {
        "axisCustom":  0,
        "axisStandard":  20,
        "contextCount":  515,
        "dts":  {
            "calculationLink":  {
                "local":  [
                    "bpsr-20220731_cal.xml"
                    ]
                },
            "definitionLink":  {
                "local":  [
                    "bpsr-20220731_def.xml"
                    ]
                },
            "inline":  {
                "local":  [
                    "organicellregen_s1.htm"
                    ]
                },
            "labelLink":  {
                "local":  [
                    "bpsr-20220731_lab.xml"
                    ]
                },
            "presentationLink":  {
                "local":  [
                    "bpsr-20220731_pre.xml"
                    ]
                },
            "schema":  {
                "local":  [
                    "bpsr-20220731.xsd"
                    ],
                "remote":  [
                    "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
                    "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
                    "http://www.xbrl.org/2005/xbrldt-2005.xsd",
                    "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
                    "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
                    "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
                    "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
                    "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
                    "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
                    "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
                    "https://xbrl.sec.gov/country/2022/country-2022.xsd",
                    "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
                    ]
                }
            },
        "elementCount":  670,
        "entityCount":  1,
        "hidden":  {
            "http://fasb.org/us-gaap/2022":  66,
            "http://organicell.com/20220731":  57,
            "http://xbrl.sec.gov/dei/2022":  2,
            "total":  125
            },
        "keyCustom":  120,
        "keyStandard":  290,
        "memberCustom":  106,
        "memberStandard":  13,
        "nsprefix":  "bpsr",
        "nsuri":  "http://organicell.com/20220731",
        "report":  {
            "R1":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "document",
                "isDefault":  "true",
                "longName":  "00000001 - Document - Cover",
                "role":  "http://organicell.com/role/Cover",
                "shortName":  "Cover",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "b",
                        "span",
                        "p",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "dei:DocumentType",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R10":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000010 - Disclosure - INVENTORIES",
                "role":  "http://organicell.com/role/Inventories",
                "shortName":  "INVENTORIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:InventoryDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R11":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000011 - Disclosure - PROPERTY AND EQUIPMENT",
                "role":  "http://organicell.com/role/PropertyAndEquipment",
                "shortName":  "PROPERTY AND EQUIPMENT",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R12":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000012 - Disclosure - LEASE OBLIGATIONS",
                "role":  "http://organicell.com/role/LeaseObligations",
                "shortName":  "LEASE OBLIGATIONS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:LesseeOperatingLeasesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R13":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000013 - Disclosure - RELATED PARTY TRANSACTIONS",
                "role":  "http://organicell.com/role/RelatedPartyTransactions",
                "shortName":  "RELATED PARTY TRANSACTIONS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R14":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000014 - Disclosure - NOTES PAYABLE",
                "role":  "http://organicell.com/role/NotesPayable",
                "shortName":  "NOTES PAYABLE",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DebtDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R15":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000015 - Disclosure - INCOME TAXES",
                "role":  "http://organicell.com/role/IncomeTaxes",
                "shortName":  "INCOME TAXES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:IncomeTaxDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R16":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000016 - Disclosure - CAPITAL STOCK",
                "role":  "http://organicell.com/role/CapitalStock",
                "shortName":  "CAPITAL STOCK",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R17":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:WarrantsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000017 - Disclosure - WARRANTS",
                "role":  "http://organicell.com/role/Warrants",
                "shortName":  "WARRANTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:WarrantsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R18":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000018 - Disclosure - COMMITMENTS AND CONTINGENCIES",
                "role":  "http://organicell.com/role/CommitmentsAndContingencies",
                "shortName":  "COMMITMENTS AND CONTINGENCIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R19":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000019 - Disclosure - LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS",
                "role":  "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperations",
                "shortName":  "LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R2":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Cash",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited)",
                "role":  "http://organicell.com/role/ConsolidatedBalanceSheets",
                "shortName":  "CONSOLIDATED BALANCE SHEETS (Unaudited)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Cash",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R20":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000020 - Disclosure - SEGMENT INFORMATION",
                "role":  "http://organicell.com/role/SegmentInformation",
                "shortName":  "SEGMENT INFORMATION",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SegmentReportingDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R21":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000021 - Disclosure - SUBSEQUENT EVENTS",
                "role":  "http://organicell.com/role/SubsequentEvents",
                "shortName":  "SUBSEQUENT EVENTS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubsequentEventsTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R22":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000022 - Disclosure - RESTRUCTURING",
                "role":  "http://organicell.com/role/Restructuring",
                "shortName":  "RESTRUCTURING",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R23":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:IrsPenaltiesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000023 - Disclosure - IRS PENALTIES",
                "role":  "http://organicell.com/role/IrsPenalties",
                "shortName":  "IRS PENALTIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:IrsPenaltiesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R24":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
                "role":  "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
                "subGroupType":  "policies",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R25":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:InventoryDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000025 - Disclosure - INVENTORIES (Tables)",
                "role":  "http://organicell.com/role/InventoriesTables",
                "shortName":  "INVENTORIES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:InventoryDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R26":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000026 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
                "role":  "http://organicell.com/role/PropertyAndEquipmentTables",
                "shortName":  "PROPERTY AND EQUIPMENT (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:PropertyPlantAndEquipmentTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R27":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000027 - Disclosure - LEASE OBLIGATIONS (Tables)",
                "role":  "http://organicell.com/role/LeaseObligationsTables",
                "shortName":  "LEASE OBLIGATIONS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R28":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000028 - Disclosure - INCOME TAXES (Tables)",
                "role":  "http://organicell.com/role/IncomeTaxesTables",
                "shortName":  "INCOME TAXES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R29":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:ScheduleOfMinimumPretransactionPricePerShareTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000029 - Disclosure - CAPITAL STOCK (Tables)",
                "role":  "http://organicell.com/role/CapitalStockTables",
                "shortName":  "CAPITAL STOCK (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:ScheduleOfMinimumPretransactionPricePerShareTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R3":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
                "role":  "http://organicell.com/role/ConsolidatedBalanceSheetsParenthetical",
                "shortName":  "CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
                "subGroupType":  "parenthetical",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CommonStockParOrStatedValuePerShare",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    }
                },
            "R30":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:SummaryOfWarrantActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000030 - Disclosure - WARRANTS (Tables)",
                "role":  "http://organicell.com/role/WarrantsTables",
                "shortName":  "WARRANTS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:SummaryOfWarrantActivityTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R31":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000031 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)",
                "role":  "http://organicell.com/role/CommitmentsAndContingenciesTables",
                "shortName":  "COMMITMENTS AND CONTINGENCIES (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R32":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000032 - Disclosure - LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS (Tables)",
                "role":  "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsTables",
                "shortName":  "LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS (Tables)",
                "subGroupType":  "tables",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R33":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:ConcentrationRiskCreditRisk",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CashFDICInsuredAmount",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000033 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
                "role":  "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:ConcentrationRiskCreditRisk",
                        "us-gaap:SignificantAccountingPoliciesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2019-11-012020-10-31",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:ConcentrationRiskPercentage1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R34":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000034 - Disclosure - GOING CONCERN (Details Narrative)",
                "role":  "http://organicell.com/role/GoingConcernDetailsNarrative",
                "shortName":  "GOING CONCERN (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R35":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "us-gaap:InventoryDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000035 - Disclosure - INVENTORIES (Details)",
                "role":  "http://organicell.com/role/InventoriesDetails",
                "shortName":  "INVENTORIES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
                        "us-gaap:InventoryDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R36":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000036 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
                "role":  "http://organicell.com/role/PropertyAndEquipmentDetails",
                "shortName":  "PROPERTY AND EQUIPMENT (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:PropertyPlantAndEquipmentTextBlock",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PropertyPlantAndEquipmentGross",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R37":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Depreciation",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000037 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)",
                "role":  "http://organicell.com/role/PropertyAndEquipmentDetailsNarrative",
                "shortName":  "PROPERTY AND EQUIPMENT (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:AdjustmentForAmortization",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R38":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000038 - Disclosure - LEASE OBLIGATIONS (Details)",
                "role":  "http://organicell.com/role/LeaseObligationsDetails",
                "shortName":  "LEASE OBLIGATIONS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R39":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000039 - Disclosure - LEASE OBLIGATIONS (Details 1)",
                "role":  "http://organicell.com/role/LeaseObligationsDetails1",
                "shortName":  "LEASE OBLIGATIONS (Details 1)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R4":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Revenues",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
                "role":  "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                "shortName":  "CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:GrossProfit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R40":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeasePayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000040 - Disclosure - LEASE OBLIGATIONS (Details Narrative)",
                "role":  "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                "shortName":  "LEASE OBLIGATIONS (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:LesseeOperatingLeasesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:OperatingLeasePayments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R41":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-10-022021-10-29",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:AggregateShares",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000041 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)",
                "role":  "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                "shortName":  "RELATED PARTY TRANSACTIONS (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-10-022021-10-29",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:AggregateShares",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R42":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2020-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000042 - Disclosure - NOTES PAYABLE (Details Narrative)",
                "role":  "http://organicell.com/role/NotesPayableDetailsNarrative",
                "shortName":  "NOTES PAYABLE (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:DebtDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-11",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentInterestRateStatedPercentage",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R43":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CurrentFederalTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000043 - Disclosure - INCOME TAXES (Details)",
                "role":  "http://organicell.com/role/IncomeTaxesDetails",
                "shortName":  "INCOME TAXES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:CurrentFederalTaxExpenseBenefit",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R44":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000044 - Disclosure - INCOME TAXES (Details 1)",
                "role":  "http://organicell.com/role/IncomeTaxesDetails1",
                "shortName":  "INCOME TAXES (Details 1)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R45":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000045 - Disclosure - INCOME TAXES (Details 2)",
                "role":  "http://organicell.com/role/IncomeTaxesDetails2",
                "shortName":  "INCOME TAXES (Details 2)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R46":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000046 - Disclosure - INCOME TAXES (Details Narrative)",
                "role":  "http://organicell.com/role/IncomeTaxesDetailsNarrative",
                "shortName":  "INCOME TAXES (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:IncomeTaxDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Pure",
                    "xsiNil":  "false"
                    }
                },
            "R47":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfMinimumPretransactionPricePerShareTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31_custom_N0.22Member",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:PretransactionPricePerShareValuation",
                    "reportCount":  1,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000047 - Disclosure - CAPITAL STOCK (Details - Minimum pre-Transaction price per share)",
                "role":  "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare",
                "shortName":  "CAPITAL STOCK (Details - Minimum pre-Transaction price per share)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R48":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfDebtAndorEquityFinancingsTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-012022-07-31_custom_Range1Member",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:AggregateFundingAmountMinimum",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000048 - Disclosure - CAPITAL STOCK (Details - Debt and/or equity financings)",
                "role":  "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                "shortName":  "CAPITAL STOCK (Details - Debt and/or equity financings)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R49":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfManagementAndConsultantsPerformanceStockPlanTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:McppSharesAwarded",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000049 - Disclosure - CAPITAL STOCK (Details - Management and consultants performance stock plan)",
                "role":  "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                "shortName":  "CAPITAL STOCK (Details - Management and consultants performance stock plan)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R5":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2019-10-31_us-gaap_CommonStockMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000005 - Statement - CONSOLIDATED CHANGES TO STOCKHOLDERS\u2019 DEFICIT",
                "role":  "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                "shortName":  "CONSOLIDATED CHANGES TO STOCKHOLDERS\u2019 DEFICIT",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2019-10-31_us-gaap_CommonStockMember",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:StockholdersEquity",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R50":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfUnvestedEquityInstrumentsOutstandingTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000050 - Disclosure - CAPITAL STOCK (Details - unvested equity instruments outstanding)",
                "role":  "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                "shortName":  "CAPITAL STOCK (Details - unvested equity instruments outstanding)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R51":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:PreferredStockSharesAuthorized",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000051 - Disclosure - CAPITAL STOCK (Details Narrative)",
                "role":  "http://organicell.com/role/CapitalStockDetailsNarrative",
                "shortName":  "CAPITAL STOCK (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-02-012020-02-12",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:ProceedsFromIssuanceOfCommonStock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R52":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:SummaryOfWarrantActivityTableTextBlock",
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31_us-gaap_WarrantMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000052 - Disclosure - WARRANTS (Details - Warrant Activity)",
                "role":  "http://organicell.com/role/WarrantsDetails-WarrantActivity",
                "shortName":  "WARRANTS (Details - Warrant Activity)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:SummaryOfWarrantActivityTableTextBlock",
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2019-11-012020-10-31_us-gaap_WarrantMember",
                    "decimals":  null,
                    "lang":  "en-US",
                    "name":  "bpsr:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R53":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensation",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000053 - Disclosure - WARRANTS (Details Narrative)",
                "role":  "http://organicell.com/role/WarrantsDetailsNarrative",
                "shortName":  "WARRANTS (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-08-012022-08-31_us-gaap_WarrantMember_us-gaap_SubsequentEventMember_custom_FiveSeparateConsultingAndEmploymentAgreementsMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "bpsr:NumberOfWarrantsPurchased",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R54":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2022-05-012022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:Revenues",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000054 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
                "role":  "http://organicell.com/role/CommitmentsAndContingenciesDetails",
                "shortName":  "COMMITMENTS AND CONTINGENCIES (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31_custom_Revenue1Member",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:Revenues",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R55":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-04-012021-04-25",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:BaseSalaryDescription",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000055 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
                "role":  "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                "shortName":  "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-04-012021-04-25",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "bpsr:BaseSalaryDescription",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R56":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000056 - Disclosure - LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS (Details)",
                "role":  "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails",
                "shortName":  "LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "us-gaap:ScheduleOfAssetRetirementObligationsTableTextBlock",
                        "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31_custom_EthanNYMember",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R57":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "N",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000057 - Disclosure - SEGMENT INFORMATION (Details Narrative)",
                "role":  "http://organicell.com/role/SegmentInformationDetailsNarrative",
                "shortName":  "SEGMENT INFORMATION (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "span",
                        "p",
                        "us-gaap:SegmentReportingDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NumberOfOperatingSegments",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "N",
                    "xsiNil":  "false"
                    }
                },
            "R58":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2020-10-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:DebtInstrumentFaceAmount",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000058 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
                "role":  "http://organicell.com/role/SubsequentEventsDetailsNarrative",
                "shortName":  "SUBSEQUENT EVENTS (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:SubsequentEventsTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-01-11_us-gaap_SubsequentEventMember",
                    "decimals":  "INF",
                    "lang":  null,
                    "name":  "us-gaap:CommonStockSharesSubscribedButUnissued",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    }
                },
            "R59":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-12-27",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SharePrice",
                    "reportCount":  1,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000059 - Disclosure - RESTRUCTURING (Details Narrative)",
                "role":  "http://organicell.com/role/RestructuringDetailsNarrative",
                "shortName":  "RESTRUCTURING (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "lang":  "en-US",
                    "name":  "bpsr:LetterOfIntentDescription",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R6":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:NetIncomeLoss",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "statement",
                "isDefault":  "false",
                "longName":  "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
                "role":  "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                "shortName":  "CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2020-11-012021-10-31",
                    "decimals":  "0",
                    "lang":  null,
                    "name":  "bpsr:BadDebtExpense",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    }
                },
            "R60":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfMinimumPretransactionPricePerShareTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2022-07-31_custom_N0.22Member",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:PretransactionPricePerShareValuation",
                    "reportCount":  1,
                    "unitRef":  "USDPShares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000060 - Disclosure - CAPITAL STOCK (Details)",
                "role":  "http://organicell.com/role/CapitalStockDetails",
                "shortName":  "CAPITAL STOCK (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R61":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfDebtAndorEquityFinancingsTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-012022-07-31_custom_Range1Member",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:AggregateFundingAmountMinimum",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000061 - Disclosure - CAPITAL STOCK (Details 1)",
                "role":  "http://organicell.com/role/CapitalStockDetails1",
                "shortName":  "CAPITAL STOCK (Details 1)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R62":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfManagementAndConsultantsPerformanceStockPlanTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "bpsr:McppSharesAwarded",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000062 - Disclosure - CAPITAL STOCK (Details 2)",
                "role":  "http://organicell.com/role/CapitalStockDetails2",
                "shortName":  "CAPITAL STOCK (Details 2)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R63":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:ScheduleOfUnvestedEquityInstrumentsOutstandingTableTextBlock",
                        "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000063 - Disclosure - CAPITAL STOCK (Details 3)",
                "role":  "http://organicell.com/role/CapitalStockDetails3",
                "shortName":  "CAPITAL STOCK (Details 3)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R64":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:SummaryOfWarrantActivityTableTextBlock",
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "AsOf2021-10-31_us-gaap_WarrantMember",
                    "decimals":  "INF",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                    "reportCount":  1,
                    "unitRef":  "Shares",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000064 - Disclosure - WARRANTS (Details)",
                "role":  "http://organicell.com/role/WarrantsDetails",
                "shortName":  "WARRANTS (Details)",
                "subGroupType":  "details",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "span",
                        "td",
                        "tr",
                        "table",
                        "bpsr:SummaryOfWarrantActivityTableTextBlock",
                        "bpsr:WarrantsDisclosureTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-012022-07-31_us-gaap_WarrantMember",
                    "decimals":  null,
                    "lang":  "en-US",
                    "name":  "bpsr:RemainingContractualTermYearsGranted",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R65":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "span",
                        "span",
                        "p",
                        "bpsr:IrsPenaltiesTextBlock",
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  "0",
                    "first":  true,
                    "lang":  null,
                    "name":  "us-gaap:IncomeTaxExaminationPenaltiesExpense",
                    "reportCount":  1,
                    "unitRef":  "USD",
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000065 - Disclosure - IRS PENALTIES (Details Narrative)",
                "role":  "http://organicell.com/role/IrsPenaltiesDetailsNarrative",
                "shortName":  "IRS PENALTIES (Details Narrative)",
                "subGroupType":  "details",
                "uniqueAnchor":  null
                },
            "R7":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NatureOfOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS",
                "role":  "http://organicell.com/role/OrganizationAndDescriptionOfBusiness",
                "shortName":  "ORGANIZATION AND DESCRIPTION OF BUSINESS",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:NatureOfOperations",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R8":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
                "role":  "http://organicell.com/role/SummaryOfSignificantAccountingPolicies",
                "shortName":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SignificantAccountingPoliciesTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                },
            "R9":  {
                "firstAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    },
                "groupType":  "disclosure",
                "isDefault":  "false",
                "longName":  "00000009 - Disclosure - GOING CONCERN",
                "role":  "http://organicell.com/role/GoingConcern",
                "shortName":  "GOING CONCERN",
                "subGroupType":  "",
                "uniqueAnchor":  {
                    "ancestors":  [
                        "body",
                        "html"
                        ],
                    "baseRef":  "organicellregen_s1.htm",
                    "contextRef":  "From2021-11-01to2022-07-31",
                    "decimals":  null,
                    "first":  true,
                    "lang":  "en-US",
                    "name":  "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
                    "reportCount":  1,
                    "unique":  true,
                    "unitRef":  null,
                    "xsiNil":  "false"
                    }
                }
            },
        "segmentCount":  133,
        "tag":  {
            "bpsr_AJBCapitalInvestmentsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "A J B Capital Investments [Member]"
                            }
                        }
                    },
                "localname":  "AJBCapitalInvestmentsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A.  Mitrani [Member]",
                            "label":  "A.  Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "AMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AccreditedInvestor1Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accredited Investor 1 [Member]"
                            }
                        }
                    },
                "localname":  "AccreditedInvestor1Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AccreditedInvestor2Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accredited Investor 2 [Member]"
                            }
                        }
                    },
                "localname":  "AccreditedInvestor2Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Accredited Investors [Member]",
                            "label":  "Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "AccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AccreditedInvestorsTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accredited Investors Two [Member]"
                            }
                        }
                    },
                "localname":  "AccreditedInvestorsTwoMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AdditionalCommitmentFee":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Commitment Fee"
                            }
                        }
                    },
                "localname":  "AdditionalCommitmentFee",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AdditionalCommitmentFeeShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Commitment Fee Shares"
                            }
                        }
                    },
                "localname":  "AdditionalCommitmentFeeShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_AdditionalCommitmentFeeShortfallObligation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Commitment fee shortfall obligation"
                            }
                        }
                    },
                "localname":  "AdditionalCommitmentFeeShortfallObligation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AdditionalCommitmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Commitment [Member]"
                            }
                        }
                    },
                "localname":  "AdditionalCommitmentMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AdditionalFairValueOfCommitmentFeeShare":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional Fair value of Commitment Fee Share"
                            }
                        }
                    },
                "localname":  "AdditionalFairValueOfCommitmentFeeShare",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AdditionalPromissoryNoteDiscount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional promissory note discount"
                            }
                        }
                    },
                "localname":  "AdditionalPromissoryNoteDiscount",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AdditionalShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Additional shares"
                            }
                        }
                    },
                "localname":  "AdditionalShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_AdministrativeStaffMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Administrative Staff [Member]"
                            }
                        }
                    },
                "localname":  "AdministrativeStaffMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AdvancesForFutureStockPurchases":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Advances for future stock purchases"
                            }
                        }
                    },
                "localname":  "AdvancesForFutureStockPurchases",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AdvisorAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Advisor Agreement [Member]"
                            }
                        }
                    },
                "localname":  "AdvisorAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AdvisorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Advisor [Member]"
                            }
                        }
                    },
                "localname":  "AdvisorMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AggregateFundingAmountMaximum":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregate funding amount, maximum"
                            }
                        }
                    },
                "localname":  "AggregateFundingAmountMaximum",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AggregateFundingAmountMinimum":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregate funding amount, minimum"
                            }
                        }
                    },
                "localname":  "AggregateFundingAmountMinimum",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AggregateIntrinsicValueExpiredforfeited":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregate Intrinsic Value, Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueExpiredforfeited",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AggregateIntrinsicValueGranted":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregate Intrinsic Value, Granted"
                            }
                        }
                    },
                "localname":  "AggregateIntrinsicValueGranted",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AggregateShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregate shares"
                            }
                        }
                    },
                "localname":  "AggregateShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_AggregatedValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Aggregated value"
                            }
                        }
                    },
                "localname":  "AggregatedValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AlbertMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Albert Mitrani [Member]",
                            "label":  "Albert Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "AlbertMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AllenMeglinMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Allen Meglin [Member]"
                            }
                        }
                    },
                "localname":  "AllenMeglinMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_AmortizationOfOidAndCommitmentFeeDiscountPromissoryNote":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Amortization of OID and commitment fee discount \u2013 Promissory Note",
                            "verboseLabel":  "Commitment fee discount"
                            }
                        }
                    },
                "localname":  "AmortizationOfOidAndCommitmentFeeDiscountPromissoryNote",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AnnualRent":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Annual rent"
                            }
                        }
                    },
                "localname":  "AnnualRent",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_AnnualSalary":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Annual salary"
                            }
                        }
                    },
                "localname":  "AnnualSalary",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_BadDebtExpense":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Bad debt expense"
                            }
                        }
                    },
                "localname":  "BadDebtExpense",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_BasaltLabAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Basalt Lab Agreement [Member]"
                            }
                        }
                    },
                "localname":  "BasaltLabAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_BaseSalary":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Base salary"
                            }
                        }
                    },
                "localname":  "BaseSalary",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_BaseSalaryDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Base salary, description"
                            }
                        }
                    },
                "localname":  "BaseSalaryDescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_BaseSalaryIncrease":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Base Salary Increase"
                            }
                        }
                    },
                "localname":  "BaseSalaryIncrease",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_Beyond100FZEMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Beyond 100 F Z E [Member]"
                            }
                        }
                    },
                "localname":  "Beyond100FZEMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CMOMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CMO [Member]"
                            }
                        }
                    },
                "localname":  "CMOMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CROAgreementDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CRO agreement discription"
                            }
                        }
                    },
                "localname":  "CROAgreementDescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_CapitalContributedByExecutive":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Capital contributed by executive"
                            }
                        }
                    },
                "localname":  "CapitalContributedByExecutive",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_CapitalContributedByExecutives":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Capital contributed by Executive"
                            }
                        }
                    },
                "localname":  "CapitalContributedByExecutives",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_CashProvidedForCreditFacility":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Cash provided for credit facility"
                            }
                        }
                    },
                "localname":  "CashProvidedForCreditFacility",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ChangeInCommitmentFeeShortfallObligation":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Change in Commitment Fee Shortfall Obligation",
                            "verboseLabel":  "Commitmnet shortfaal obligation"
                            }
                        }
                    },
                "localname":  "ChangeInCommitmentFeeShortfallObligation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ChangeInCommitmentFeeShortfallObligationValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ChangeInCommitmentFeeShortfallObligationValue",
                            "negatedLabel":  "Change in Commitment Fee Shortfall Obligation"
                            }
                        }
                    },
                "localname":  "ChangeInCommitmentFeeShortfallObligationValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ChiefMedicalOfficerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Medical Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefMedicalOfficerMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CommitmentFeeShortfallObligation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CommitmentFeeShortfallObligation",
                            "verboseLabel":  "Commitment Fee Shortfall Obligation"
                            }
                        }
                    },
                "localname":  "CommitmentFeeShortfallObligation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_CommonSharesIssuableUponExerciseOfWarrantsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Common Shares Issuable Upon Exercise of Warrants [Member]",
                            "label":  "Common Shares Issuable Upon Exercise Of Warrants [Member]"
                            }
                        }
                    },
                "localname":  "CommonSharesIssuableUponExerciseOfWarrantsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CommonStockIssuedAsCommitmentFeeForPromissoryNote":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CommonStockIssuedAsCommitmentFeeForPromissoryNote",
                            "verboseLabel":  "Common stock issued as commitment fee for Promissory Note"
                            }
                        }
                    },
                "localname":  "CommonStockIssuedAsCommitmentFeeForPromissoryNote",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_Commonstockdescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Common stock description"
                            }
                        }
                    },
                "localname":  "Commonstockdescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_ConsuktantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consuktant [Member]"
                            }
                        }
                    },
                "localname":  "ConsuktantMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantAgreementsDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant agreements,description"
                            }
                        }
                    },
                "localname":  "ConsultantAgreementsDescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_ConsultantFiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant Five [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantFiveMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantFourMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant Four [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantFourMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant 1 [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantOneMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant Three [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantThreeMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultant 2 [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantTwoMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantsAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultants Agreement [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantsAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultantsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consultants [Member]"
                            }
                        }
                    },
                "localname":  "ConsultantsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultingAgreement1Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consulting Agreement 1 [Member]"
                            }
                        }
                    },
                "localname":  "ConsultingAgreement1Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ConsultingAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Consulting Agreement [Member]"
                            }
                        }
                    },
                "localname":  "ConsultingAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ContractResearchOrganizationOutstanding":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Contract research organization outstanding"
                            }
                        }
                    },
                "localname":  "ContractResearchOrganizationOutstanding",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ConversionOfDebtAndAccruedInterestIntoCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Conversion of debt and accrued interest into common stock"
                            }
                        }
                    },
                "localname":  "ConversionOfDebtAndAccruedInterestIntoCommonStock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ConversionOfDebtAndAccruedInterestShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Conversion of debt and accrued interest, shares"
                            }
                        }
                    },
                "localname":  "ConversionOfDebtAndAccruedInterestShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_ConversionOfDebtAndAccruedInterestValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Conversion of debt and accrued interest"
                            }
                        }
                    },
                "localname":  "ConversionOfDebtAndAccruedInterestValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ConvertibleDebentures":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ConvertibleDebentures",
                            "verboseLabel":  "Convertible debentures"
                            }
                        }
                    },
                "localname":  "ConvertibleDebentures",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_CustomerOneMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer One [Member]"
                            }
                        }
                    },
                "localname":  "CustomerOneMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CustomerThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer Three [Member]"
                            }
                        }
                    },
                "localname":  "CustomerThreeMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_CustomerTwoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer Two [Member]"
                            }
                        }
                    },
                "localname":  "CustomerTwoMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_DebtIssuedOriginalDiscountRate":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt issued original discount rate"
                            }
                        }
                    },
                "localname":  "DebtIssuedOriginalDiscountRate",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_DisclosureIrsPenaltiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Irs Penalties",
                            "verboseLabel":  "Capital Stock"
                            }
                        }
                    },
                "localname":  "DisclosureIrsPenaltiesAbstract",
                "nsuri":  "http://organicell.com/20220731",
                "xbrltype":  "stringItemType"
                },
            "bpsr_DisclosureLeaseObligationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease Obligations"
                            }
                        }
                    },
                "localname":  "DisclosureLeaseObligationsAbstract",
                "nsuri":  "http://organicell.com/20220731",
                "xbrltype":  "stringItemType"
                },
            "bpsr_DisclosureWarrantsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Warrants"
                            }
                        }
                    },
                "localname":  "DisclosureWarrantsAbstract",
                "nsuri":  "http://organicell.com/20220731",
                "xbrltype":  "stringItemType"
                },
            "bpsr_DistributorMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Distributor [Member]"
                            }
                        }
                    },
                "localname":  "DistributorMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_DrAllenMeglinMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dr.  Allen Meglin [Member]"
                            }
                        }
                    },
                "localname":  "DrAllenMeglinMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_DrGeorgeShapiroMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dr George Shapiro [Member]"
                            }
                        }
                    },
                "localname":  "DrGeorgeShapiroMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_DrMariMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Dr.  Mari Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "DrMariMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_DrMariaInesMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Dr.  Maria Ines Mitrani [Member]",
                            "label":  "Dr.  Maria Ines Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "DrMariaInesMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_EightAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Eight Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "EightAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_EightIndividualsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Eight Individuals [Member]"
                            }
                        }
                    },
                "localname":  "EightIndividualsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_EmployeeAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Employee Agreement [Member]"
                            }
                        }
                    },
                "localname":  "EmployeeAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_EthanNYMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ethan NY [Member]",
                            "label":  "Ethan NY [Member]"
                            }
                        }
                    },
                "localname":  "EthanNYMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ExchangeOfAccountsPayableForStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exchange of accounts payable for stock"
                            }
                        }
                    },
                "localname":  "ExchangeOfAccountsPayableForStock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ExchangeOfAccountsPayableForStockShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exchange of accounts payable for stock, Shares"
                            }
                        }
                    },
                "localname":  "ExchangeOfAccountsPayableForStockShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_ExchangeOfAccountsPayableInterestIntoCommonStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exchange of accounts payable interest into common stock"
                            }
                        }
                    },
                "localname":  "ExchangeOfAccountsPayableInterestIntoCommonStock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ExchangeOfDebt":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exchange of debt"
                            }
                        }
                    },
                "localname":  "ExchangeOfDebt",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ExchangeOfDebtShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Exchange of debt, shares"
                            }
                        }
                    },
                "localname":  "ExchangeOfDebtShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_ExecutiveBonusSharesIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Executive bonus shares issued"
                            }
                        }
                    },
                "localname":  "ExecutiveBonusSharesIssued",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_ExecutiveEmploymentAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Executive Employment Agreements [Member]",
                            "label":  "Executive Employment Agreement [Member]"
                            }
                        }
                    },
                "localname":  "ExecutiveEmploymentAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ExecutiveEmploymentAgreementsdescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Executive employment agreements description"
                            }
                        }
                    },
                "localname":  "ExecutiveEmploymentAgreementsdescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_ExpensesAllowances":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Expenses allowances"
                            }
                        }
                    },
                "localname":  "ExpensesAllowances",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_FairValueOfCommitmentFeeShare":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Fair value of Commitment Fee Share"
                            }
                        }
                    },
                "localname":  "FairValueOfCommitmentFeeShare",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_FinanceLeaseEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Finance lease equipment [Member]"
                            }
                        }
                    },
                "localname":  "FinanceLeaseEquipmentMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FinanceLeaseObligations":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "FinanceLeaseObligations",
                            "verboseLabel":  "Finance lease obligations"
                            }
                        }
                    },
                "localname":  "FinanceLeaseObligations",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_FirstSupplierMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "First Supplier [Member]"
                            }
                        }
                    },
                "localname":  "FirstSupplierMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FiveAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Five Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "FiveAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FiveSeparateConsultingAndEmploymentAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Five Separate Consulting And Employment Agreements [Member]"
                            }
                        }
                    },
                "localname":  "FiveSeparateConsultingAndEmploymentAgreementsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FourAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Four Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "FourAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FourIndividualsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Four Individuals [Member]"
                            }
                        }
                    },
                "localname":  "FourIndividualsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_FundingFacilityMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Funding Facility [Member]"
                            }
                        }
                    },
                "localname":  "FundingFacilityMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_GainFromWriteoffOfLiabilitiesAttributableToDiscontinuedOperations":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "GainFromWriteoffOfLiabilitiesAttributableToDiscontinuedOperations",
                            "negatedLabel":  "Gain from write-off of liabilities attributable to discontinued operations"
                            }
                        }
                    },
                "localname":  "GainFromWriteoffOfLiabilitiesAttributableToDiscontinuedOperations",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_GainFromWriteoffOfLiabilitiesAttributableToDiscontinuedOperationsValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Gain from write-off of liabilities attributable to discontinued operations"
                            }
                        }
                    },
                "localname":  "GainFromWriteoffOfLiabilitiesAttributableToDiscontinuedOperationsValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_GeneralSurgicalFloridaMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "General Surgical Florida [Member]"
                            }
                        }
                    },
                "localname":  "GeneralSurgicalFloridaMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_GeorgeShapiroMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "George Shapiro [Member]"
                            }
                        }
                    },
                "localname":  "GeorgeShapiroMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_IanBothwellMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Ian Bothwell [Member]"
                            }
                        }
                    },
                "localname":  "IanBothwellMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_IanTBothwellMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Ian T.  Bothwell [Member]",
                            "label":  "Ian T.  Bothwell [Member]"
                            }
                        }
                    },
                "localname":  "IanTBothwellMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ImputedInterest":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ImputedInterest",
                            "negatedLabel":  "Less: imputed interest"
                            }
                        }
                    },
                "localname":  "ImputedInterest",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ImputedInterestOperatingLeaseLiabilities":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Imputed Interest Operating Lease Liabilities",
                            "negatedLabel":  "Less: imputed interest"
                            }
                        }
                    },
                "localname":  "ImputedInterestOperatingLeaseLiabilities",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_IncreaseDecreaseInAccruedLiabilitiesToManagement":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  10.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "IncreaseDecreaseInAccruedLiabilitiesToManagement",
                            "verboseLabel":  "Accrued liabilities to management"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccruedLiabilitiesToManagement",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_IncreasingAnnualSalary":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Increasing annual salary"
                            }
                        }
                    },
                "localname":  "IncreasingAnnualSalary",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_IncreasingAnnualSalarys":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "IncreasingAnnualSalarys",
                            "verboseLabel":  "Increasing annual salary"
                            }
                        }
                    },
                "localname":  "IncreasingAnnualSalarys",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_IncrementalSalary":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Incremental salary"
                            }
                        }
                    },
                "localname":  "IncrementalSalary",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_InitialCommitmentFeeShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Initial Commitment Fee Shares"
                            }
                        }
                    },
                "localname":  "InitialCommitmentFeeShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_InvestorThreeMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Investor Three [Member]"
                            }
                        }
                    },
                "localname":  "InvestorThreeMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_IrsPenaltiesTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "IRS PENALTIES"
                            }
                        }
                    },
                "localname":  "IrsPenaltiesTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/IrsPenalties"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_IssuanceOfDiscount":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Issuance of discount"
                            }
                        }
                    },
                "localname":  "IssuanceOfDiscount",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_JHDarbieCoMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "J H Darbie Co [Member]"
                            }
                        }
                    },
                "localname":  "JHDarbieCoMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_JHDarbieMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "J H Darbie [Member]"
                            }
                        }
                    },
                "localname":  "JHDarbieMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_LawsuitSettlementByCash":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lawsuit settlement by cash"
                            }
                        }
                    },
                "localname":  "LawsuitSettlementByCash",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_LawsuitSettlementByIssuanceOfRestrictedCommonStock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lawsuit settlement by issuance of restricted common stock"
                            }
                        }
                    },
                "localname":  "LawsuitSettlementByIssuanceOfRestrictedCommonStock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_LeaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Lease Agreement [Member]"
                            }
                        }
                    },
                "localname":  "LeaseAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_LetterOfIntentDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Letter of intent description"
                            }
                        }
                    },
                "localname":  "LetterOfIntentDescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_ManagementServicesOrganizationMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Management Services Organization [Member]"
                            }
                        }
                    },
                "localname":  "ManagementServicesOrganizationMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ManufacturingEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Manufacturing Equipment [Member]",
                            "label":  "Manufacturing Equipment [Member]"
                            }
                        }
                    },
                "localname":  "ManufacturingEquipmentMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MariLunaMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mari Luna [Member]"
                            }
                        }
                    },
                "localname":  "MariLunaMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MariaIMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maria I.  Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "MariaIMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_McppRemainingSharesAvailable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mcpp remaining shares available"
                            }
                        }
                    },
                "localname":  "McppRemainingSharesAvailable",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_McppSharesAwarded":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mcpp shares awarded"
                            }
                        }
                    },
                "localname":  "McppSharesAwarded",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_MedicalAdvisorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Medical Advisors [Member]"
                            }
                        }
                    },
                "localname":  "MedicalAdvisorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MiamiLabLeaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Miami Lab Lease Agreement [Member]"
                            }
                        }
                    },
                "localname":  "MiamiLabLeaseAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MichaelCarbonaraMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Michael Carbonara [Member]"
                            }
                        }
                    },
                "localname":  "MichaelCarbonaraMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MonthlyRentExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Monthly rent expense [Default Label]",
                            "verboseLabel":  "Monthly rent expense"
                            }
                        }
                    },
                "localname":  "MonthlyRentExpense",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_MrBothwellMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mr.  Bothwell [Member]"
                            }
                        }
                    },
                "localname":  "MrBothwellMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MrCarbonaraMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mr.  Carbonara [Member]"
                            }
                        }
                    },
                "localname":  "MrCarbonaraMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MrMitraniMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mr.  Mitrani [Member]"
                            }
                        }
                    },
                "localname":  "MrMitraniMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_MrZuckerMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Mr.  Zucker [Member]"
                            }
                        }
                    },
                "localname":  "MrZuckerMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_N0.22Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "$0.22"
                            }
                        }
                    },
                "localname":  "N0.22Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_N0.34Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "$0.34"
                            }
                        }
                    },
                "localname":  "N0.34Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_N0.45Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "$0.45"
                            }
                        }
                    },
                "localname":  "N0.45Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_N0.54Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "$0.54"
                            }
                        }
                    },
                "localname":  "N0.54Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_N19AccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "19 Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "N19AccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_NetLossPerCommonShareBasicAndDiluted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Net loss per common share - basic and diluted"
                            }
                        }
                    },
                "localname":  "NetLossPerCommonShareBasicAndDiluted",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "bpsr_Newlyissuedcommonstock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Newly issued common stock"
                            }
                        }
                    },
                "localname":  "Newlyissuedcommonstock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NineAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nine Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "NineAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_NineIndividualsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Nine Individuals [Member]"
                            }
                        }
                    },
                "localname":  "NineIndividualsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_NonExecutiveBoardMembersMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Non-executive Board Members [Member]"
                            }
                        }
                    },
                "localname":  "NonExecutiveBoardMembersMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_NonexecutiveBoardBonusSharesIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Non-executive board bonus shares issued"
                            }
                        }
                    },
                "localname":  "NonexecutiveBoardBonusSharesIssued",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NumberOfCashlessWarrantsGranted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of cashless warrants granted"
                            }
                        }
                    },
                "localname":  "NumberOfCashlessWarrantsGranted",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NumberOfCommonStockIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of common stock issued",
                            "verboseLabel":  "Number of common stock purchased"
                            }
                        }
                    },
                "localname":  "NumberOfCommonStockIssued",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NumberOfRestrictedCommonStockVested":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of restricted common stock vested"
                            }
                        }
                    },
                "localname":  "NumberOfRestrictedCommonStockVested",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NumberOfUnregisteredCommonStockIssued":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of unregistered common stock issued"
                            }
                        }
                    },
                "localname":  "NumberOfUnregisteredCommonStockIssued",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_NumberOfWarrantsPurchased":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of warrants purchased"
                            }
                        }
                    },
                "localname":  "NumberOfWarrantsPurchased",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_OidDiscountOnProceedsReceivedFromPromissoryNote":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "OID discount on proceeds received from Promissory Note"
                            }
                        }
                    },
                "localname":  "OidDiscountOnProceedsReceivedFromPromissoryNote",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_OneAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "One Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "OneAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_OneIndividualMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "One Individual [Member]"
                            }
                        }
                    },
                "localname":  "OneIndividualMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_OperatingAndFinanceLeaseObligation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating and finance lease obligation"
                            }
                        }
                    },
                "localname":  "OperatingAndFinanceLeaseObligation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_OperatingAndFinanceLeaseObligationsPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating Lease Obligations"
                            }
                        }
                    },
                "localname":  "OperatingAndFinanceLeaseObligationsPolicyTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_OperatingLeaseRightOfUseAssets":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating lease - right of use assets",
                            "verboseLabel":  "Operating lease \u2013 right of use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAssets",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_OperatingLeasedEquipmentPerUnit":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Operating leased equipment, per unit"
                            }
                        }
                    },
                "localname":  "OperatingLeasedEquipmentPerUnit",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_OriginalIssueDiscount":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Original issue discount"
                            }
                        }
                    },
                "localname":  "OriginalIssueDiscount",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PayableInCashOrInStock":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payable in cash or in stock"
                            }
                        }
                    },
                "localname":  "PayableInCashOrInStock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PaymentForDebtSettlement":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Payment for debt settlement"
                            }
                        }
                    },
                "localname":  "PaymentForDebtSettlement",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PaymentsOnFinanceLease":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "PaymentsOnFinanceLease",
                            "negatedLabel":  "Payments on finance lease"
                            }
                        }
                    },
                "localname":  "PaymentsOnFinanceLease",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PerformanceShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Performance Shares"
                            }
                        }
                    },
                "localname":  "PerformanceShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_Plan2021Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "2021 Plan Member"
                            }
                        }
                    },
                "localname":  "Plan2021Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Planandshareexchangeagreement":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Plan and share exchange agreement"
                            }
                        }
                    },
                "localname":  "Planandshareexchangeagreement",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_PretransactionPricePerShareValuation":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Pre-transaction price per share valuation"
                            }
                        }
                    },
                "localname":  "PretransactionPricePerShareValuation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "bpsr_ProceedsFromAdvancesForFutureStockPurchasesValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ProceedsFromAdvancesForFutureStockPurchasesValue",
                            "verboseLabel":  "Advances for future stock purchases"
                            }
                        }
                    },
                "localname":  "ProceedsFromAdvancesForFutureStockPurchasesValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_ProductsPurchasedFromCompany":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Products purchased from the company"
                            }
                        }
                    },
                "localname":  "ProductsPurchasedFromCompany",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PromissoryNoteIssuedForPastDueProfessionalFees":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Promissory note issued for past due Professional Fees"
                            }
                        }
                    },
                "localname":  "PromissoryNoteIssuedForPastDueProfessionalFees",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PromissoryNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Promissory Note [Member]"
                            }
                        }
                    },
                "localname":  "PromissoryNoteMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_PromissoryNoteNetOfDebtDiscount":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Promissory Note, net of debt discount"
                            }
                        }
                    },
                "localname":  "PromissoryNoteNetOfDebtDiscount",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PurchaseOfFixedAssetsIncludedInAccountsPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Purchase of fixed assets included in accounts payable"
                            }
                        }
                    },
                "localname":  "PurchaseOfFixedAssetsIncludedInAccountsPayable",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_PurchaseOfRestrictedCommonShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Purchase of restricted common shares"
                            }
                        }
                    },
                "localname":  "PurchaseOfRestrictedCommonShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_Range1Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Range 1 [Member]"
                            }
                        }
                    },
                "localname":  "Range1Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Range2Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Range 2 [Member]"
                            }
                        }
                    },
                "localname":  "Range2Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Range3Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Range 3 [Member]"
                            }
                        }
                    },
                "localname":  "Range3Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_RemainingContractualTermYearsGranted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Remaining Contractual Term (years) Granted [Default Label]",
                            "verboseLabel":  "Remaining Contractual Term (years) Granted"
                            }
                        }
                    },
                "localname":  "RemainingContractualTermYearsGranted",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails"
                    ],
                "xbrltype":  "durationItemType"
                },
            "bpsr_RentExpenses":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Rent expenses [Default Label]",
                            "verboseLabel":  "Rent expenses"
                            }
                        }
                    },
                "localname":  "RentExpenses",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_RepublicAssetHoldingsLLCMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Republic Asset Holdings LLC [Member]"
                            }
                        }
                    },
                "localname":  "RepublicAssetHoldingsLLCMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Revenue1Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue 1 [Member]"
                            }
                        }
                    },
                "localname":  "Revenue1Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Revenue2Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue 2 [Member]"
                            }
                        }
                    },
                "localname":  "Revenue2Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Revenue3Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue 3 [Member]"
                            }
                        }
                    },
                "localname":  "Revenue3Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Revenue4Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue 4 [Member]"
                            }
                        }
                    },
                "localname":  "Revenue4Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Revenue5Member":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Revenue 5 [Member]"
                            }
                        }
                    },
                "localname":  "Revenue5Member",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SaleOfCommonStockShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of common stock, Shares"
                            }
                        }
                    },
                "localname":  "SaleOfCommonStockShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_SaleOfCommonStockValue":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sale of common stock"
                            }
                        }
                    },
                "localname":  "SaleOfCommonStockValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_SalesExecutiveMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sales Executive [Member]"
                            }
                        }
                    },
                "localname":  "SalesExecutiveMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SalesExecutivesMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sales Executives [Member]"
                            }
                        }
                    },
                "localname":  "SalesExecutivesMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_Salesexecutivesdescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sales executives,description."
                            }
                        }
                    },
                "localname":  "Salesexecutivesdescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_ScheduleOfDebtAndorEquityFinancingsTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of debt and/or equity financings"
                            }
                        }
                    },
                "localname":  "ScheduleOfDebtAndorEquityFinancingsTableTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_ScheduleOfManagementAndConsultantsPerformanceStockPlanTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of management and consultants performance stock plan"
                            }
                        }
                    },
                "localname":  "ScheduleOfManagementAndConsultantsPerformanceStockPlanTableTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_ScheduleOfMinimumPretransactionPricePerShareTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of minimum pre-transaction price per share"
                            }
                        }
                    },
                "localname":  "ScheduleOfMinimumPretransactionPricePerShareTableTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_ScheduleOfUnvestedEquityInstrumentsOutstandingTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of unvested equity instruments outstanding"
                            }
                        }
                    },
                "localname":  "ScheduleOfUnvestedEquityInstrumentsOutstandingTableTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_SecondLeaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Second Lease Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SecondLeaseAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SecondSupplierMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Second Supplier [Member]"
                            }
                        }
                    },
                "localname":  "SecondSupplierMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SecuritiesPurchaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Securities Purchase Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SecuritiesPurchaseAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SequencingPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sequencing"
                            }
                        }
                    },
                "localname":  "SequencingPolicyTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_SeriesCNonConvertiblePreferredStockMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Series C Non Convertible Preferred Stock [Member]"
                            }
                        }
                    },
                "localname":  "SeriesCNonConvertiblePreferredStockMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SettlementAndGeneralReleaseAgreementMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Settlement And General Release Agreement [Member]"
                            }
                        }
                    },
                "localname":  "SettlementAndGeneralReleaseAgreementMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SevenAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Seven Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "SevenAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SeveralAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Several Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "SeveralAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitureInPeriod":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Number of Non-Vested Shares, Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitureInPeriod",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted-Average Grant Date Value, Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "bpsr_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Remaining Contractual Term (years) Outstanding ending balance"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "durationItemType"
                },
            "bpsr_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Remaining Contractual Term (years) Granted"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "durationItemType"
                },
            "bpsr_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateVestedFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted-Average Grant Date Value, Vested"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateVestedFairValue",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "bpsr_SharesGrantedDescriptions":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shares Granted, descriptions"
                            }
                        }
                    },
                "localname":  "SharesGrantedDescriptions",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_SharesVestedDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Shares vested, description"
                            }
                        }
                    },
                "localname":  "SharesVestedDescription",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "bpsr_SinnreichMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Sinnreich [Member]"
                            }
                        }
                    },
                "localname":  "SinnreichMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_SkycrestHoldingsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Skycrest Holdings [Member]"
                            }
                        }
                    },
                "localname":  "SkycrestHoldingsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_StateBonusDepreciation":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "State bonus depreciation"
                            }
                        }
                    },
                "localname":  "StateBonusDepreciation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockIssuedForFutureServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "StockIssuedForFutureServices",
                            "verboseLabel":  "Stock issued for future services"
                            }
                        }
                    },
                "localname":  "StockIssuedForFutureServices",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockIssuedInSettlementOfLitigation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "StockIssuedInSettlementOfLitigation",
                            "negatedLabel":  "Stock issued in settlement of litigation"
                            }
                        }
                    },
                "localname":  "StockIssuedInSettlementOfLitigation",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockIssuedInSettlementOfLitigationShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock issued in settlement of litigation, Shares"
                            }
                        }
                    },
                "localname":  "StockIssuedInSettlementOfLitigationShares",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_StockIssuedInSettlementOfLitigations":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock issued in settlement of litigation"
                            }
                        }
                    },
                "localname":  "StockIssuedInSettlementOfLitigations",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockPurchasedFromPaymentsDueOnAccountsPayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock purchased from payments due on accounts payable"
                            }
                        }
                    },
                "localname":  "StockPurchasedFromPaymentsDueOnAccountsPayable",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockSubscriptionReceivable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock subscription receivable"
                            }
                        }
                    },
                "localname":  "StockSubscriptionReceivable",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_StockSubscriptionsReceivablePolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stock Subscriptions Receivable"
                            }
                        }
                    },
                "localname":  "StockSubscriptionsReceivablePolicyTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_SummaryOfWarrantActivityTableTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Schedule of Summary of Warrant Activity"
                            }
                        }
                    },
                "localname":  "SummaryOfWarrantActivityTableTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/WarrantsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_ThirdPartyMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Third Party [Member]"
                            }
                        }
                    },
                "localname":  "ThirdPartyMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ThreeAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Three Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "ThreeAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_ThreeIndividualsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Three Individuals [Member]"
                            }
                        }
                    },
                "localname":  "ThreeIndividualsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_TotalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "TotalIncomeTaxExpenseBenefit",
                            "totalLabel":  "Total income tax expense (benefit)"
                            }
                        }
                    },
                "localname":  "TotalIncomeTaxExpenseBenefit",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_TotalPropertyAndEquipmentNetBeforeLeaseholdImprovements":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Total property and equipment, net before leasehold improvements"
                            }
                        }
                    },
                "localname":  "TotalPropertyAndEquipmentNetBeforeLeaseholdImprovements",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "bpsr_TwoAccreditedInvestorsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Two Accredited Investors [Member]"
                            }
                        }
                    },
                "localname":  "TwoAccreditedInvestorsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_TwoIndividualsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Two Individuals [Member]"
                            }
                        }
                    },
                "localname":  "TwoIndividualsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_UnsecuredPromissoryNoteMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Unsecured Promissory Note [Member]"
                            }
                        }
                    },
                "localname":  "UnsecuredPromissoryNoteMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_VPAgreementsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "V P Agreements [Member]"
                            }
                        }
                    },
                "localname":  "VPAgreementsMember",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "bpsr_WarrantsDisclosureTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "WARRANTS"
                            }
                        }
                    },
                "localname":  "WarrantsDisclosureTextBlock",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/Warrants"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "bpsr_WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Weighted average number of common shares outstanding - basic and diluted"
                            }
                        }
                    },
                "localname":  "WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "bpsr_WorkingCapital":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Working capital",
                            "label":  "Working capital deficit",
                            "verboseLabel":  "Working capital"
                            }
                        }
                    },
                "localname":  "WorkingCapital",
                "nsuri":  "http://organicell.com/20220731",
                "presentation":  [
                    "http://organicell.com/role/GoingConcernDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_AmendmentDescription":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of changes contained within amended document.",
                            "label":  "Amendment Description"
                            }
                        }
                    },
                "localname":  "AmendmentDescription",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_AmendmentFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
                            "label":  "Amendment Flag"
                            }
                        }
                    },
                "localname":  "AmendmentFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AnnualInformationForm":  {
                "auth_ref":  [
                    "r555"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
                            "label":  "Annual Information Form"
                            }
                        }
                    },
                "localname":  "AnnualInformationForm",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_AuditedAnnualFinancialStatements":  {
                "auth_ref":  [
                    "r555"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
                            "label":  "Audited Annual Financial Statements"
                            }
                        }
                    },
                "localname":  "AuditedAnnualFinancialStatements",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_CityAreaCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Area code of city",
                            "label":  "City Area Code"
                            }
                        }
                    },
                "localname":  "CityAreaCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CountryRegion":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Region code of country",
                            "label":  "Country Region"
                            }
                        }
                    },
                "localname":  "CountryRegion",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_CoverAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cover page.",
                            "label":  "Cover [Abstract]"
                            }
                        }
                    },
                "localname":  "CoverAbstract",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "xbrltype":  "stringItemType"
                },
            "dei_CurrentFiscalYearEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "End date of current fiscal year in the format --MM-DD.",
                            "label":  "Current Fiscal Year End Date"
                            }
                        }
                    },
                "localname":  "CurrentFiscalYearEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "gMonthDayItemType"
                },
            "dei_DocumentAccountingStandard":  {
                "auth_ref":  [
                    "r554"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S.  GAAP', 'International Financial Reporting Standards', or 'Other'.",
                            "label":  "Document Accounting Standard"
                            }
                        }
                    },
                "localname":  "DocumentAccountingStandard",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "accountingStandardItemType"
                },
            "dei_DocumentAnnualReport":  {
                "auth_ref":  [
                    "r552",
                    "r554",
                    "r555"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an annual report.",
                            "label":  "Document Annual Report"
                            }
                        }
                    },
                "localname":  "DocumentAnnualReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentFiscalPeriodFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
                            "label":  "Document Fiscal Period Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalPeriodFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "fiscalPeriodItemType"
                },
            "dei_DocumentFiscalYearFocus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "This is focus fiscal year of the document report in YYYY format.  For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus.  Example: 2006.",
                            "label":  "Document Fiscal Year Focus"
                            }
                        }
                    },
                "localname":  "DocumentFiscalYearFocus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "gYearItemType"
                },
            "dei_DocumentPeriodEndDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
                            "label":  "Document Period End Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodEndDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentPeriodStartDate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The start date of the period covered in the document, in YYYY-MM-DD format.",
                            "label":  "Document Period Start Date"
                            }
                        }
                    },
                "localname":  "DocumentPeriodStartDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentQuarterlyReport":  {
                "auth_ref":  [
                    "r553"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as an quarterly report.",
                            "label":  "Document Quarterly Report"
                            }
                        }
                    },
                "localname":  "DocumentQuarterlyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentRegistrationStatement":  {
                "auth_ref":  [
                    "r541"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a registration statement.",
                            "label":  "Document Registration Statement"
                            }
                        }
                    },
                "localname":  "DocumentRegistrationStatement",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentShellCompanyEventDate":  {
                "auth_ref":  [
                    "r554"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date of event requiring a shell company report.",
                            "label":  "Document Shell Company Event Date"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyEventDate",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "dateItemType"
                },
            "dei_DocumentShellCompanyReport":  {
                "auth_ref":  [
                    "r554"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
                            "label":  "Document Shell Company Report"
                            }
                        }
                    },
                "localname":  "DocumentShellCompanyReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentTransitionReport":  {
                "auth_ref":  [
                    "r556"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a form used as a transition report.",
                            "label":  "Document Transition Report"
                            }
                        }
                    },
                "localname":  "DocumentTransitionReport",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_DocumentType":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc).  The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
                            "label":  "Document Type"
                            }
                        }
                    },
                "localname":  "DocumentType",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "submissionTypeItemType"
                },
            "dei_DocumentsIncorporatedByReferenceTextBlock":  {
                "auth_ref":  [
                    "r544"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Documents incorporated by reference.",
                            "label":  "Documents Incorporated by Reference [Text Block]"
                            }
                        }
                    },
                "localname":  "DocumentsIncorporatedByReferenceTextBlock",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "dei_EntityAddressAddressLine1":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 1 such as Attn, Building Name, Street Name",
                            "label":  "Entity Address, Address Line One"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine1",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine2":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 2 such as Street or Suite number",
                            "label":  "Entity Address, Address Line Two"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine2",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressAddressLine3":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Address Line 3 such as an Office Park",
                            "label":  "Entity Address, Address Line Three"
                            }
                        }
                    },
                "localname":  "EntityAddressAddressLine3",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCityOrTown":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the City or Town",
                            "label":  "Entity Address, City or Town"
                            }
                        }
                    },
                "localname":  "EntityAddressCityOrTown",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressCountry":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "ISO 3166-1 alpha-2 country code.",
                            "label":  "Entity Address, Country"
                            }
                        }
                    },
                "localname":  "EntityAddressCountry",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "countryCodeItemType"
                },
            "dei_EntityAddressPostalZipCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Code for the postal or zip code",
                            "label":  "Entity Address, Postal Zip Code"
                            }
                        }
                    },
                "localname":  "EntityAddressPostalZipCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityAddressStateOrProvince":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the state or province.",
                            "label":  "Entity Address, State or Province"
                            }
                        }
                    },
                "localname":  "EntityAddressStateOrProvince",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "stateOrProvinceItemType"
                },
            "dei_EntityBankruptcyProceedingsReportingCurrent":  {
                "auth_ref":  [
                    "r547"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
                            "label":  "Entity Bankruptcy Proceedings, Reporting Current"
                            }
                        }
                    },
                "localname":  "EntityBankruptcyProceedingsReportingCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityCentralIndexKey":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC.  It is commonly abbreviated as CIK.",
                            "label":  "Entity Central Index Key"
                            }
                        }
                    },
                "localname":  "EntityCentralIndexKey",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "centralIndexKeyItemType"
                },
            "dei_EntityCommonStockSharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report.  Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
                            "label":  "Entity Common Stock, Shares Outstanding"
                            }
                        }
                    },
                "localname":  "EntityCommonStockSharesOutstanding",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "dei_EntityCurrentReportingStatus":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Current Reporting Status"
                            }
                        }
                    },
                "localname":  "EntityCurrentReportingStatus",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "All the names of the entities being reported upon in a document.  Any legal structure used to conduct activities or to hold assets.  Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts.  This item does not include business and geographical segments which are included in the geographical or business segments domains."
                            }
                        }
                    },
                "localname":  "EntityDomain",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "dei_EntityEmergingGrowthCompany":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if registrant meets the emerging growth company criteria.",
                            "label":  "Entity Emerging Growth Company"
                            }
                        }
                    },
                "localname":  "EntityEmergingGrowthCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityExTransitionPeriod":  {
                "auth_ref":  [
                    "r561"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
                            "label":  "Elected Not To Use the Extended Transition Period"
                            }
                        }
                    },
                "localname":  "EntityExTransitionPeriod",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityFileNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Commission file number.  The field allows up to 17 characters.  The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
                            "label":  "Entity File Number"
                            }
                        }
                    },
                "localname":  "EntityFileNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "fileNumberItemType"
                },
            "dei_EntityFilerCategory":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate whether the registrant is one of the following:  Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer.  Definitions of these categories are stated in Rule 12b-2 of the Exchange Act.  This information should be based on the registrant's current or most recent filing containing the related disclosure.",
                            "label":  "Entity Filer Category"
                            }
                        }
                    },
                "localname":  "EntityFilerCategory",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "filerCategoryItemType"
                },
            "dei_EntityIncorporationStateCountryCode":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Two-character EDGAR code representing the state or country of incorporation.",
                            "label":  "Entity Incorporation, State or Country Code"
                            }
                        }
                    },
                "localname":  "EntityIncorporationStateCountryCode",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "edgarStateCountryItemType"
                },
            "dei_EntityInteractiveDataCurrent":  {
                "auth_ref":  [
                    "r558"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
                            "label":  "Entity Interactive Data Current"
                            }
                        }
                    },
                "localname":  "EntityInteractiveDataCurrent",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityPrimarySicNumber":  {
                "auth_ref":  [
                    "r555"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Primary Standard Industrial Classification (SIC) Number for the Entity.",
                            "label":  "Entity Primary SIC Number"
                            }
                        }
                    },
                "localname":  "EntityPrimarySicNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "sicNumberItemType"
                },
            "dei_EntityPublicFloat":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
                            "label":  "Entity Public Float"
                            }
                        }
                    },
                "localname":  "EntityPublicFloat",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "dei_EntityRegistrantName":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
                            "label":  "Entity Registrant Name"
                            }
                        }
                    },
                "localname":  "EntityRegistrantName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_EntityShellCompany":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
                            "label":  "Entity Shell Company"
                            }
                        }
                    },
                "localname":  "EntityShellCompany",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntitySmallBusiness":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicates that the company is a Smaller Reporting Company (SRC).",
                            "label":  "Entity Small Business"
                            }
                        }
                    },
                "localname":  "EntitySmallBusiness",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_EntityTaxIdentificationNumber":  {
                "auth_ref":  [
                    "r543"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
                            "label":  "Entity Tax Identification Number"
                            }
                        }
                    },
                "localname":  "EntityTaxIdentificationNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "employerIdItemType"
                },
            "dei_EntityVoluntaryFilers":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
                            "label":  "Entity Voluntary Filers"
                            }
                        }
                    },
                "localname":  "EntityVoluntaryFilers",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_EntityWellKnownSeasonedIssuer":  {
                "auth_ref":  [
                    "r559"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
                            "label":  "Entity Well-known Seasoned Issuer"
                            }
                        }
                    },
                "localname":  "EntityWellKnownSeasonedIssuer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "yesNoItemType"
                },
            "dei_Extension":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Extension number for local phone number.",
                            "label":  "Extension"
                            }
                        }
                    },
                "localname":  "Extension",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_LegalEntityAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The set of legal entities associated with a report.",
                            "label":  "Legal Entity [Axis]"
                            }
                        }
                    },
                "localname":  "LegalEntityAxis",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "dei_LocalPhoneNumber":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Local phone number for entity.",
                            "label":  "Local Phone Number"
                            }
                        }
                    },
                "localname":  "LocalPhoneNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "normalizedStringItemType"
                },
            "dei_NoTradingSymbolFlag":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true only for a security having no trading symbol.",
                            "label":  "No Trading Symbol Flag"
                            }
                        }
                    },
                "localname":  "NoTradingSymbolFlag",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "trueItemType"
                },
            "dei_OtherReportingStandardItemNumber":  {
                "auth_ref":  [
                    "r554"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
                            "label":  "Other Reporting Standard Item Number"
                            }
                        }
                    },
                "localname":  "OtherReportingStandardItemNumber",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "otherReportingStandardItemNumberItemType"
                },
            "dei_PreCommencementIssuerTenderOffer":  {
                "auth_ref":  [
                    "r548"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
                            "label":  "Pre-commencement Issuer Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementIssuerTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_PreCommencementTenderOffer":  {
                "auth_ref":  [
                    "r549"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
                            "label":  "Pre-commencement Tender Offer"
                            }
                        }
                    },
                "localname":  "PreCommencementTenderOffer",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_Security12bTitle":  {
                "auth_ref":  [
                    "r542"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(b) registered security.",
                            "label":  "Title of 12(b) Security"
                            }
                        }
                    },
                "localname":  "Security12bTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_Security12gTitle":  {
                "auth_ref":  [
                    "r546"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Title of a 12(g) registered security.",
                            "label":  "Title of 12(g) Security"
                            }
                        }
                    },
                "localname":  "Security12gTitle",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "securityTitleItemType"
                },
            "dei_SecurityExchangeName":  {
                "auth_ref":  [
                    "r545"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Name of the Exchange on which a security is registered.",
                            "label":  "Security Exchange Name"
                            }
                        }
                    },
                "localname":  "SecurityExchangeName",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "edgarExchangeCodeItemType"
                },
            "dei_SecurityReportingObligation":  {
                "auth_ref":  [
                    "r550"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
                            "label":  "Security Reporting Obligation"
                            }
                        }
                    },
                "localname":  "SecurityReportingObligation",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "securityReportingObligationItemType"
                },
            "dei_SolicitingMaterial":  {
                "auth_ref":  [
                    "r551"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
                            "label":  "Soliciting Material"
                            }
                        }
                    },
                "localname":  "SolicitingMaterial",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "dei_TradingSymbol":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Trading symbol of an instrument as listed on an exchange.",
                            "label":  "Trading Symbol"
                            }
                        }
                    },
                "localname":  "TradingSymbol",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "tradingSymbolItemType"
                },
            "dei_WrittenCommunications":  {
                "auth_ref":  [
                    "r560"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
                            "label":  "Written Communications"
                            }
                        }
                    },
                "localname":  "WrittenCommunications",
                "nsuri":  "http://xbrl.sec.gov/dei/2022",
                "presentation":  [
                    "http://organicell.com/role/Cover"
                    ],
                "xbrltype":  "booleanItemType"
                },
            "srt_BoardOfDirectorsChairmanMember":  {
                "auth_ref":  [
                    "r185"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Board of Directors Chairman [Member]"
                            }
                        }
                    },
                "localname":  "BoardOfDirectorsChairmanMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_ChiefFinancialOfficerMember":  {
                "auth_ref":  [
                    "r185"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Chief Financial Officer [Member]"
                            }
                        }
                    },
                "localname":  "ChiefFinancialOfficerMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_CounterpartyNameAxis":  {
                "auth_ref":  [
                    "r54",
                    "r56",
                    "r114",
                    "r115",
                    "r246",
                    "r282"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Counterparty Name [Axis]"
                            }
                        }
                    },
                "localname":  "CounterpartyNameAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_DirectorMember":  {
                "auth_ref":  [
                    "r185"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Director [Member]"
                            }
                        }
                    },
                "localname":  "DirectorMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MajorCustomersAxis":  {
                "auth_ref":  [
                    "r183",
                    "r306",
                    "r307",
                    "r503"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Customer [Axis]"
                            }
                        }
                    },
                "localname":  "MajorCustomersAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_MaximumMember":  {
                "auth_ref":  [
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r245",
                    "r281",
                    "r311",
                    "r312",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r502",
                    "r504",
                    "r537",
                    "r538"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Maximum [Member]"
                            }
                        }
                    },
                "localname":  "MaximumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_MinimumMember":  {
                "auth_ref":  [
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r245",
                    "r281",
                    "r311",
                    "r312",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r502",
                    "r504",
                    "r537",
                    "r538"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Minimum [Member]"
                            }
                        }
                    },
                "localname":  "MinimumMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_NameOfMajorCustomerDomain":  {
                "auth_ref":  [
                    "r183",
                    "r306",
                    "r307",
                    "r503"
                    ],
                "localname":  "NameOfMajorCustomerDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RangeAxis":  {
                "auth_ref":  [
                    "r214",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r245",
                    "r281",
                    "r309",
                    "r311",
                    "r312",
                    "r341",
                    "r342",
                    "r343",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r502",
                    "r504",
                    "r537",
                    "r538"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statistical Measurement [Axis]"
                            }
                        }
                    },
                "localname":  "RangeAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_RangeMember":  {
                "auth_ref":  [
                    "r214",
                    "r223",
                    "r224",
                    "r225",
                    "r226",
                    "r245",
                    "r281",
                    "r309",
                    "r311",
                    "r312",
                    "r341",
                    "r342",
                    "r343",
                    "r451",
                    "r452",
                    "r453",
                    "r454",
                    "r455",
                    "r456",
                    "r457",
                    "r502",
                    "r504",
                    "r537",
                    "r538"
                    ],
                "localname":  "RangeMember",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_RepurchaseAgreementCounterpartyNameDomain":  {
                "auth_ref":  [
                    "r55",
                    "r56",
                    "r114",
                    "r115",
                    "r246",
                    "r282"
                    ],
                "localname":  "RepurchaseAgreementCounterpartyNameDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "srt_TitleOfIndividualAxis":  {
                "auth_ref":  [
                    "r185",
                    "r441"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Title of Individual [Axis]"
                            }
                        }
                    },
                "localname":  "TitleOfIndividualAxis",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "srt_TitleOfIndividualWithRelationshipToEntityDomain":  {
                "auth_ref":  [
                    ],
                "localname":  "TitleOfIndividualWithRelationshipToEntityDomain",
                "nsuri":  "http://fasb.org/srt/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AccountingPoliciesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Accounting Policies [Abstract]"
                            }
                        }
                    },
                "localname":  "AccountingPoliciesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
                            "label":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "AccountsPayableAndAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccountsReceivableNetCurrent":  {
                "auth_ref":  [
                    "r186",
                    "r187"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
                            "label":  "Accounts receivable, net of allowance for bad debts"
                            }
                        }
                    },
                "localname":  "AccountsReceivableNetCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedBonusesCurrent":  {
                "auth_ref":  [
                    "r46"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Bonus"
                            }
                        }
                    },
                "localname":  "AccruedBonusesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r46"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.  Examples include taxes, interest, rent and utilities.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued liabilities to management"
                            }
                        }
                    },
                "localname":  "AccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r15",
                    "r209"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
                            "label":  "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
                            "negatedLabel":  "Less: accumulated depreciation"
                            }
                        }
                    },
                "localname":  "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapital":  {
                "auth_ref":  [
                    "r29",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder.  Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
                            "label":  "Additional paid-in capital"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapital",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdditionalPaidInCapitalMember":  {
                "auth_ref":  [
                    "r119",
                    "r120",
                    "r121",
                    "r348",
                    "r349",
                    "r350",
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
                            "label":  "Additional Paid-in Capital [Member]"
                            }
                        }
                    },
                "localname":  "AdditionalPaidInCapitalMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_AdjustmentForAmortization":  {
                "auth_ref":  [
                    "r92",
                    "r205"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
                            "label":  "Amortization expense"
                            }
                        }
                    },
                "localname":  "AdjustmentForAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentOfWarrantsGrantedForServices":  {
                "auth_ref":  [
                    "r92"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Adjustment for noncash service expenses paid for by granting of warrants.",
                            "label":  "Services paid"
                            }
                        }
                    },
                "localname":  "AdjustmentOfWarrantsGrantedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Adjustments to reconcile net loss to net cash used in operating activities:"
                            }
                        }
                    },
                "localname":  "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpense":  {
                "auth_ref":  [
                    "r346"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for award under share-based payment arrangement.  Excludes amount capitalized.",
                            "label":  "Stock-based compensation expense"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after tax, of expense for award under share-based payment arrangement.",
                            "label":  "Compensation"
                            }
                        }
                    },
                "localname":  "AllocatedShareBasedCompensationExpenseNetOfTax",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AmortizationOfFinancingCosts":  {
                "auth_ref":  [
                    "r69",
                    "r92",
                    "r265",
                    "r417"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense attributable to debt issuance costs.",
                            "label":  "Amortization of Debt Issuance Costs"
                            }
                        }
                    },
                "localname":  "AmortizationOfFinancingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":  {
                "auth_ref":  [
                    "r137"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
                            "label":  "Antidilutive securities excluded from computation of earnings per share"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis":  {
                "auth_ref":  [
                    "r137"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of antidilutive security.",
                            "label":  "Antidilutive Securities [Axis]"
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AntidilutiveSecuritiesNameDomain":  {
                "auth_ref":  [
                    "r137"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
                            }
                        }
                    },
                "localname":  "AntidilutiveSecuritiesNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ArrangementsAndNonarrangementTransactionsMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
                            }
                        }
                    },
                "localname":  "ArrangementsAndNonarrangementTransactionsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Assets":  {
                "auth_ref":  [
                    "r17",
                    "r109",
                    "r166",
                    "r170",
                    "r176",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r389",
                    "r391",
                    "r406",
                    "r445",
                    "r447",
                    "r476",
                    "r491"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized.  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets [Default Label]",
                            "totalLabel":  "TOTAL ASSETS"
                            }
                        }
                    },
                "localname":  "Assets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "ASSETS"
                            }
                        }
                    },
                "localname":  "AssetsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsCurrent":  {
                "auth_ref":  [
                    "r10",
                    "r40",
                    "r109",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r233",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r389",
                    "r391",
                    "r406",
                    "r445",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer).  Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
                            "label":  "Assets, Current",
                            "totalLabel":  "Total Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_AssetsCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Assets"
                            }
                        }
                    },
                "localname":  "AssetsCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent":  {
                "auth_ref":  [
                    "r1",
                    "r2",
                    "r3",
                    "r4",
                    "r5",
                    "r206",
                    "r211"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
                            "label":  "Assets"
                            }
                        }
                    },
                "localname":  "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_BasisOfAccountingPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
                            "label":  "Basis of Presentation"
                            }
                        }
                    },
                "localname":  "BasisOfAccountingPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_Cash":  {
                "auth_ref":  [
                    "r13",
                    "r447",
                    "r511",
                    "r512"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of currency on hand as well as demand deposits with banks or financial institutions.  Includes other kinds of accounts that have the general characteristics of demand deposits.  Excludes cash and cash equivalents within disposal group and discontinued operation.",
                            "label":  "Cash"
                            }
                        }
                    },
                "localname":  "Cash",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashAndCashEquivalentsPolicyTextBlock":  {
                "auth_ref":  [
                    "r95"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents.  Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
                            "label":  "Cash Equivalents"
                            }
                        }
                    },
                "localname":  "CashAndCashEquivalentsPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":  {
                "auth_ref":  [
                    "r86",
                    "r94",
                    "r100"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage.  Excludes amount for disposal group and discontinued operations.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
                            "periodEndLabel":  "Cash at end of period",
                            "periodStartLabel":  "Cash at beginning of period"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect":  {
                "auth_ref":  [
                    "r86",
                    "r407"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change.  Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.  Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
                            "label":  "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
                            "totalLabel":  "(Decrease) in cash"
                            }
                        }
                    },
                "localname":  "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFDICInsuredAmount":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.",
                            "label":  "FDIC limits per institutions"
                            }
                        }
                    },
                "localname":  "CashFDICInsuredAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "NON-CASH INVESTING AND FINANCING TRANSACTIONS:"
                            }
                        }
                    },
                "localname":  "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfStockDomain":  {
                "auth_ref":  [
                    "r24",
                    "r26",
                    "r27",
                    "r106",
                    "r109",
                    "r131",
                    "r132",
                    "r133",
                    "r135",
                    "r136",
                    "r142",
                    "r143",
                    "r144",
                    "r193",
                    "r229",
                    "r234",
                    "r235",
                    "r236",
                    "r240",
                    "r241",
                    "r279",
                    "r280",
                    "r284",
                    "r288",
                    "r296",
                    "r406",
                    "r557"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Share of stock differentiated by the voting rights the holder receives.  Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
                            }
                        }
                    },
                "localname":  "ClassOfStockDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ClassOfStockLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Class of Stock [Line Items]"
                            }
                        }
                    },
                "localname":  "ClassOfStockLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Exercise price per share or per unit of warrants or rights outstanding.",
                            "label":  "Warrant exercise price per share",
                            "verboseLabel":  "Exercise price of warrants"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of securities into which each warrant or right may be converted.  For example, but not limited to, each warrant may be converted into two shares.",
                            "label":  "Warrants to purchase share of common stock",
                            "terseLabel":  "Warrant to purchase shares of common stock",
                            "verboseLabel":  "Number of warrant shares issued"
                            }
                        }
                    },
                "localname":  "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
                            }
                        }
                    },
                "localname":  "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingencies":  {
                "auth_ref":  [
                    "r51",
                    "r481",
                    "r496"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
                            "label":  "Commitments and contingencies"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingencies",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Commitments and Contingencies Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r220",
                    "r221",
                    "r222",
                    "r227",
                    "r533"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for commitments and contingencies.",
                            "label":  "COMMITMENTS AND CONTINGENCIES"
                            }
                        }
                    },
                "localname":  "CommitmentsAndContingenciesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingencies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance":  {
                "auth_ref":  [
                    "r52"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate number of common shares reserved for future issuance.",
                            "label":  "Number of shares reserved"
                            }
                        }
                    },
                "localname":  "CommonStockCapitalSharesReservedForFutureIssuance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockMember":  {
                "auth_ref":  [
                    "r119",
                    "r120",
                    "r399"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Stock that is subordinate to all other stock of the issuer.",
                            "label":  "Common Stock [Member]"
                            }
                        }
                    },
                "localname":  "CommonStockMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_CommonStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of common stock.",
                            "label":  "Common stock, par value"
                            }
                        }
                    },
                "localname":  "CommonStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheetsParenthetical"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable":  {
                "auth_ref":  [
                    "r27"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of subscription receivable from investors who have been allocated common stock.",
                            "label":  "Common Stock, Share Subscribed but Unissued, Subscriptions Receivable",
                            "verboseLabel":  "Stock subscription receivable"
                            }
                        }
                    },
                "localname":  "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommonStockSharesAuthorized":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Common stock, shares authorized"
                            }
                        }
                    },
                "localname":  "CommonStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesIssued":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury).  These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized.  Shares issued include shares outstanding and shares held in the treasury.",
                            "label":  "Common stock, shares issued"
                            }
                        }
                    },
                "localname":  "CommonStockSharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesOutstanding":  {
                "auth_ref":  [
                    "r27",
                    "r296"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of common stock outstanding.  Common stock represent the ownership interest in a corporation.",
                            "label":  "Common stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "CommonStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheetsParenthetical",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockSharesSubscribedButUnissued":  {
                "auth_ref":  [
                    "r27"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public.  When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds.  In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.",
                            "label":  "Unissued common stock"
                            }
                        }
                    },
                "localname":  "CommonStockSharesSubscribedButUnissued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CommonStockValue":  {
                "auth_ref":  [
                    "r27",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer).  This item includes treasury stock repurchased by the entity.  Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
                            "label":  "Common stock, $0.001 par value, 2,500,000,000 shares authorized; 1,206,126,390 and 1,132,361,005 shares issued and outstanding, respectively"
                            }
                        }
                    },
                "localname":  "CommonStockValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CommonStockVotingRights":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Description of voting rights of common stock.  Includes eligibility to vote and votes per share owned.  Include also, if any, unusual voting rights.",
                            "label":  "Voting right, percentage"
                            }
                        }
                    },
                "localname":  "CommonStockVotingRights",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CommonUnitIssued":  {
                "auth_ref":  [
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of common units issued of limited liability company (LLC).",
                            "label":  "Shares of newly issued common stock"
                            }
                        }
                    },
                "localname":  "CommonUnitIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ComputerEquipmentMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
                            "label":  "Computer Equipment [Member]"
                            }
                        }
                    },
                "localname":  "ComputerEquipmentMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConcentrationRiskByTypeAxis":  {
                "auth_ref":  [
                    "r151",
                    "r152",
                    "r183",
                    "r404",
                    "r405",
                    "r510",
                    "r532"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
                            "label":  "Concentration Risk Type [Axis]"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ConcentrationRiskCreditRisk":  {
                "auth_ref":  [
                    "r148",
                    "r488"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for credit risk.",
                            "label":  "Concentrations of Credit Risk"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskCreditRisk",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ConcentrationRiskPercentage1":  {
                "auth_ref":  [
                    "r151",
                    "r152",
                    "r183",
                    "r404",
                    "r405"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
                            "label":  "Concentration credit risk percentage"
                            }
                        }
                    },
                "localname":  "ConcentrationRiskPercentage1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ConcentrationRiskTypeDomain":  {
                "auth_ref":  [
                    "r151",
                    "r152",
                    "r183",
                    "r404",
                    "r405",
                    "r532"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
                            }
                        }
                    },
                "localname":  "ConcentrationRiskTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ConstructionInProgressGross":  {
                "auth_ref":  [
                    "r208"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of structure or a modification to a structure under construction.  Includes recently completed structures or modifications to structures that have not been placed into service.",
                            "label":  "Construction in progress",
                            "verboseLabel":  "Construction in Progress"
                            }
                        }
                    },
                "localname":  "ConstructionInProgressGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails",
                    "http://organicell.com/role/PropertyAndEquipmentDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConstructionInProgressMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Structure or a modification to a structure under construction.  Includes recently completed structures or modifications to structures that have not been placed into service.",
                            "label":  "Construction in Progress [Member]"
                            }
                        }
                    },
                "localname":  "ConstructionInProgressMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ContractualObligation":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
                            "label":  "Commitment Fee Shortfall Obligation",
                            "verboseLabel":  "Commitment fee shortfall obligation"
                            }
                        }
                    },
                "localname":  "ContractualObligation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConversionOfStockSharesConverted1":  {
                "auth_ref":  [
                    "r97",
                    "r98",
                    "r99"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares converted in a noncash (or part noncash) transaction.  Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of shares",
                            "verboseLabel":  "Common stock shares converted"
                            }
                        }
                    },
                "localname":  "ConversionOfStockSharesConverted1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ConvertibleDebt":  {
                "auth_ref":  [
                    "r22",
                    "r478",
                    "r492"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
                            "label":  "Convertible debentures",
                            "verboseLabel":  "Promissory note"
                            }
                        }
                    },
                "localname":  "ConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtCurrent":  {
                "auth_ref":  [
                    "r19"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer.  Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Debentures payable"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleDebtFairValueDisclosures":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
                            "label":  "Fair value of converted stock"
                            }
                        }
                    },
                "localname":  "ConvertibleDebtFairValueDisclosures",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertibleNotesPayableCurrent":  {
                "auth_ref":  [
                    "r46"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable.  Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
                            "label":  "Discount"
                            }
                        }
                    },
                "localname":  "ConvertibleNotesPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion":  {
                "auth_ref":  [
                    "r25",
                    "r26",
                    "r291",
                    "r297",
                    "r300"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued for each share of convertible preferred stock that is converted.",
                            "label":  "Conversion of convertible shares"
                            }
                        }
                    },
                "localname":  "ConvertiblePreferredStockSharesIssuedUponConversion",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_CostOfRevenue":  {
                "auth_ref":  [
                    "r72",
                    "r109",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r406"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
                            "label":  "Cost of revenues"
                            }
                        }
                    },
                "localname":  "CostOfRevenue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentFederalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r110",
                    "r372",
                    "r379"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CurrentIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations.  Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
                            "label":  "Federal"
                            }
                        }
                    },
                "localname":  "CurrentFederalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r110",
                    "r372",
                    "r379",
                    "r381"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
                            "label":  "Current Income Tax Expense (Benefit)",
                            "totalLabel":  "Current Income Tax Expense (Benefit)"
                            }
                        }
                    },
                "localname":  "CurrentIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current:"
                            }
                        }
                    },
                "localname":  "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_CurrentStateAndLocalTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r110",
                    "r372",
                    "r379"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CurrentIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations.  Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
                            "label":  "State"
                            }
                        }
                    },
                "localname":  "CurrentStateAndLocalTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtConversionConvertedInstrumentAmount1":  {
                "auth_ref":  [
                    "r97",
                    "r99"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Conversion of debt"
                            }
                        }
                    },
                "localname":  "DebtConversionConvertedInstrumentAmount1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtConversionConvertedInstrumentSharesIssued1":  {
                "auth_ref":  [
                    "r97",
                    "r99"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
                            "label":  "Debt conversion, shares issued",
                            "verboseLabel":  "Debt conversion, converted instrument, shares issued"
                            }
                        }
                    },
                "localname":  "DebtConversionConvertedInstrumentSharesIssued1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_DebtConversionOriginalDebtAmount1":  {
                "auth_ref":  [
                    "r97",
                    "r99"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
                            "label":  "Cash payment",
                            "verboseLabel":  "Conversion convertible amount"
                            }
                        }
                    },
                "localname":  "DebtConversionOriginalDebtAmount1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtCurrent":  {
                "auth_ref":  [
                    "r21"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of debt and lease obligation, classified as current.",
                            "label":  "Debt outstanding"
                            }
                        }
                    },
                "localname":  "DebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Debt Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "DebtDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtDisclosureTextBlock":  {
                "auth_ref":  [
                    "r105",
                    "r248",
                    "r249",
                    "r250",
                    "r251",
                    "r252",
                    "r253",
                    "r254",
                    "r259",
                    "r266",
                    "r267",
                    "r268",
                    "r274"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
                            "label":  "NOTES PAYABLE"
                            }
                        }
                    },
                "localname":  "DebtDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayable"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DebtInstrumentAxis":  {
                "auth_ref":  [
                    "r19",
                    "r20",
                    "r22",
                    "r108",
                    "r117",
                    "r242",
                    "r243",
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r249",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r418",
                    "r477",
                    "r478",
                    "r489"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
                            "label":  "Debt Instrument [Axis]"
                            }
                        }
                    },
                "localname":  "DebtInstrumentAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DebtInstrumentConvertibleConversionPrice1":  {
                "auth_ref":  [
                    "r244",
                    "r269"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The price per share of the conversion feature embedded in the debt instrument.",
                            "label":  "Conversion Price",
                            "verboseLabel":  "Convertible share price"
                            }
                        }
                    },
                "localname":  "DebtInstrumentConvertibleConversionPrice1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_DebtInstrumentFaceAmount":  {
                "auth_ref":  [
                    "r242",
                    "r270",
                    "r271",
                    "r416",
                    "r418",
                    "r419"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face (par) amount of debt instrument at time of issuance.",
                            "label":  "Principal amount"
                            }
                        }
                    },
                "localname":  "DebtInstrumentFaceAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtInstrumentInterestRateDuringPeriod":  {
                "auth_ref":  [
                    "r48",
                    "r262",
                    "r416"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The average effective interest rate during the reporting period.",
                            "label":  "Debt Instrument, Interest Rate During Period",
                            "verboseLabel":  "Interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateDuringPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentInterestRateStatedPercentage":  {
                "auth_ref":  [
                    "r48",
                    "r243"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Contractual interest rate for funds borrowed, under the debt agreement.",
                            "label":  "Interest rate"
                            }
                        }
                    },
                "localname":  "DebtInstrumentInterestRateStatedPercentage",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_DebtInstrumentMaturityDate":  {
                "auth_ref":  [
                    "r49",
                    "r245",
                    "r401"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
                            "label":  "Maturity date"
                            }
                        }
                    },
                "localname":  "DebtInstrumentMaturityDate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "dateItemType"
                },
            "us-gaap_DebtInstrumentNameDomain":  {
                "auth_ref":  [
                    "r50",
                    "r108",
                    "r117",
                    "r242",
                    "r243",
                    "r244",
                    "r245",
                    "r246",
                    "r247",
                    "r249",
                    "r255",
                    "r256",
                    "r257",
                    "r258",
                    "r260",
                    "r261",
                    "r262",
                    "r263",
                    "r264",
                    "r265",
                    "r270",
                    "r271",
                    "r272",
                    "r273",
                    "r418"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
                            }
                        }
                    },
                "localname":  "DebtInstrumentNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_DebtInstrumentPeriodicPayment":  {
                "auth_ref":  [
                    "r50",
                    "r487"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the required periodic payments including both interest and principal payments.",
                            "label":  "Periodic payment"
                            }
                        }
                    },
                "localname":  "DebtInstrumentPeriodicPayment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts":  {
                "auth_ref":  [
                    "r75"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Represents the charge against earnings during the period for commitment fees and debt issuance expenses.",
                            "label":  "Commitment fee"
                            }
                        }
                    },
                "localname":  "DebtRelatedCommitmentFeesAndDebtIssuanceCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice":  {
                "auth_ref":  [
                    "r196"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount at purchase price of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), purchased with credit deterioration.",
                            "label":  "Purchase price"
                            }
                        }
                    },
                "localname":  "DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredFederalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r110",
                    "r373",
                    "r379"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations.  Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
                            "label":  "Deferred Federal Income Tax Expense (Benefit)",
                            "verboseLabel":  "Federal"
                            }
                        }
                    },
                "localname":  "DeferredFederalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r92",
                    "r110",
                    "r373",
                    "r379",
                    "r380",
                    "r381"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
                            "label":  "Deferred Income Tax Expense (Benefit)",
                            "totalLabel":  "Deferred Income Tax Expense (Benefit)"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredIncomeTaxesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred:"
                            }
                        }
                    },
                "localname":  "DeferredIncomeTaxesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredRevenue":  {
                "auth_ref":  [
                    "r23"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
                            "label":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "DeferredRevenue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r110",
                    "r373",
                    "r379"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations.  Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
                            "label":  "Deferred State and Local Income Tax Expense (Benefit)",
                            "verboseLabel":  "State"
                            }
                        }
                    },
                "localname":  "DeferredStateAndLocalIncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsGross":  {
                "auth_ref":  [
                    "r364"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
                            "label":  "Deferred Tax Assets, Gross",
                            "totalLabel":  "Total deferred tax assets:"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsGrossAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Assets:"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsGrossAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredTaxAssetsLiabilitiesNet":  {
                "auth_ref":  [
                    "r366"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
                            "label":  "Deferred Tax Assets, Net",
                            "totalLabel":  "Net deferred tax assets"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsLiabilitiesNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards.  Excludes state and local operating loss carryforwards.",
                            "label":  "Net operating loss carryforward-Federal"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
                            "label":  "Net operating loss carryforward-State"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsOther":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
                            "label":  "Deferred Tax Assets, Other",
                            "verboseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
                            "label":  "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
                            "verboseLabel":  "Stock based compensation"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsGross",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee bonuses.",
                            "label":  "Accrued compensation"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r365"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
                            "label":  "Deferred Tax Assets, Valuation Allowance",
                            "negatedLabel":  "Valuation Allowance"
                            }
                        }
                    },
                "localname":  "DeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxLiabilities":  {
                "auth_ref":  [
                    "r357",
                    "r366"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_DeferredTaxAssetsLiabilitiesNet",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
                            "label":  "Deferred Tax Liabilities, Net",
                            "totalLabel":  "Total deferred tax liabilities:"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DeferredTaxLiabilitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Deferred Tax Liabilities:"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r370",
                    "r371"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails2":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_DeferredTaxLiabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
                            "label":  "Property and equipment"
                            }
                        }
                    },
                "localname":  "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails2"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_Depreciation":  {
                "auth_ref":  [
                    "r92",
                    "r207"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives.  Includes production and non-production related depreciation.",
                            "label":  "Depreciation expense"
                            }
                        }
                    },
                "localname":  "Depreciation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/PropertyAndEquipmentDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DepreciationDepletionAndAmortization":  {
                "auth_ref":  [
                    "r92",
                    "r164"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
                            "label":  "Depreciation and amortization expense"
                            }
                        }
                    },
                "localname":  "DepreciationDepletionAndAmortization",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DerivativesPolicyTextBlock":  {
                "auth_ref":  [
                    "r116",
                    "r393",
                    "r394",
                    "r395",
                    "r396",
                    "r397"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for its derivative instruments and hedging activities.",
                            "label":  "Valuation of Derivatives"
                            }
                        }
                    },
                "localname":  "DerivativesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Discontinued Operations and Disposal Groups [Abstract]"
                            }
                        }
                    },
                "localname":  "DiscontinuedOperationsAndDisposalGroupsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent":  {
                "auth_ref":  [
                    "r1",
                    "r2",
                    "r3",
                    "r206",
                    "r211"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
                            "label":  "Accounts payable"
                            }
                        }
                    },
                "localname":  "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent":  {
                "auth_ref":  [
                    "r1",
                    "r2",
                    "r3",
                    "r206",
                    "r211"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
                            "label":  "Accrued expenses"
                            }
                        }
                    },
                "localname":  "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r6",
                    "r212"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure related to a disposal group.  Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
                            "label":  "LIABILITIES ATTRIBUTABLE TO DISCONTINUED OPERATIONS"
                            }
                        }
                    },
                "localname":  "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperations"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_DueFromRelatedParties":  {
                "auth_ref":  [
                    "r28",
                    "r113",
                    "r232",
                    "r234",
                    "r235",
                    "r239",
                    "r240",
                    "r241",
                    "r439",
                    "r480",
                    "r498"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.",
                            "label":  "Due from Related Parties",
                            "verboseLabel":  "Related parties"
                            }
                        }
                    },
                "localname":  "DueFromRelatedParties",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DueToAffiliateCurrent":  {
                "auth_ref":  [
                    "r18",
                    "r113",
                    "r439",
                    "r513"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Advances payable"
                            }
                        }
                    },
                "localname":  "DueToAffiliateCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_DueToRelatedPartiesCurrent":  {
                "auth_ref":  [
                    "r41",
                    "r113",
                    "r232",
                    "r234",
                    "r235",
                    "r239",
                    "r240",
                    "r241",
                    "r439"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount as of the balance sheet date of obligations due all related parties.  For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Related parties"
                            }
                        }
                    },
                "localname":  "DueToRelatedPartiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_EarningsPerSharePolicyTextBlock":  {
                "auth_ref":  [
                    "r137",
                    "r138"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security.  Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
                            "label":  "Net Income (Loss) Per Common Share"
                            }
                        }
                    },
                "localname":  "EarningsPerSharePolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r111",
                    "r359",
                    "r382"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
                            "label":  "Statutory income tax rate"
                            }
                        }
                    },
                "localname":  "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_EquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Equity [Abstract]"
                            }
                        }
                    },
                "localname":  "EquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_EquityComponentDomain":  {
                "auth_ref":  [
                    "r0",
                    "r60",
                    "r61",
                    "r62",
                    "r119",
                    "r120",
                    "r121",
                    "r123",
                    "r128",
                    "r130",
                    "r141",
                    "r194",
                    "r296",
                    "r304",
                    "r348",
                    "r349",
                    "r350",
                    "r375",
                    "r376",
                    "r399",
                    "r408",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r435",
                    "r505",
                    "r506",
                    "r507"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
                            }
                        }
                    },
                "localname":  "EquityComponentDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_FairValueAdjustmentOfWarrants":  {
                "auth_ref":  [
                    "r92",
                    "r275"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense (income) related to adjustment to fair value of warrant liability.",
                            "label":  "Grant date fair value of warrants issued"
                            }
                        }
                    },
                "localname":  "FairValueAdjustmentOfWarrants",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FairValueOfFinancialInstrumentsPolicy":  {
                "auth_ref":  [
                    "r402",
                    "r403"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for determining the fair value of financial instruments.",
                            "label":  "Fair Value of Financial Instruments"
                            }
                        }
                    },
                "localname":  "FairValueOfFinancialInstrumentsPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FinanceLeaseLiability":  {
                "auth_ref":  [
                    "r424",
                    "r431"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease.",
                            "label":  "Present value of finance lease liabilities"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r424"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
                            "label":  "Finance lease obligations"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock":  {
                "auth_ref":  [
                    "r431"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of undiscounted cash flows of finance lease liability.  Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
                            "label":  "Schedule of Financial Lease Payment"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityMaturityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_FinanceLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r424"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
                            "label":  "Long term finance lease obligations"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
                            "label":  "Finance Lease, Liability, to be Paid",
                            "totalLabel":  "Total undiscounted finance lease payments"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Thereafter"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "2022"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "2026"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFive",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "2025"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearFour",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "2024"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_FinanceLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "2023"
                            }
                        }
                    },
                "localname":  "FinanceLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r429",
                    "r432"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Finance leases"
                            }
                        }
                    },
                "localname":  "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_GeneralAndAdministrativeExpense":  {
                "auth_ref":  [
                    "r74"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "General and administrative expenses"
                            }
                        }
                    },
                "localname":  "GeneralAndAdministrativeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_GrossProfit":  {
                "auth_ref":  [
                    "r71",
                    "r109",
                    "r166",
                    "r169",
                    "r172",
                    "r175",
                    "r178",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r406"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_OperatingIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
                            "label":  "Gross Profit",
                            "totalLabel":  "Gross profit"
                            }
                        }
                    },
                "localname":  "GrossProfit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":  {
                "auth_ref":  [
                    "r65",
                    "r166",
                    "r169",
                    "r172",
                    "r175",
                    "r178",
                    "r474",
                    "r482",
                    "r485",
                    "r500"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
                            "label":  "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
                            "totalLabel":  "Loss before taxes"
                            }
                        }
                    },
                "localname":  "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeStatementAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Statement [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeStatementAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Income Tax Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncomeTaxDisclosureTextBlock":  {
                "auth_ref":  [
                    "r111",
                    "r360",
                    "r362",
                    "r368",
                    "r377",
                    "r383",
                    "r385",
                    "r386",
                    "r387"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for income taxes.  Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
                            "label":  "INCOME TAXES"
                            }
                        }
                    },
                "localname":  "IncomeTaxDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxes"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxExaminationPenaltiesAccrued":  {
                "auth_ref":  [
                    "r361"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of estimated penalties accrued as of the balance sheet date arising from income tax examinations.",
                            "label":  "Accrued tax penalties"
                            }
                        }
                    },
                "localname":  "IncomeTaxExaminationPenaltiesAccrued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetailsNarrative",
                    "http://organicell.com/role/IrsPenaltiesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxExaminationPenaltiesExpense":  {
                "auth_ref":  [
                    "r361"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of estimated penalties recognized in the period arising from income tax examinations.",
                            "label":  "Penalties"
                            }
                        }
                    },
                "localname":  "IncomeTaxExaminationPenaltiesExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetailsNarrative",
                    "http://organicell.com/role/IrsPenaltiesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxExpenseBenefit":  {
                "auth_ref":  [
                    "r112",
                    "r129",
                    "r130",
                    "r165",
                    "r358",
                    "r378",
                    "r384",
                    "r501"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetIncomeLoss",
                        "weight":  -1.0
                        },
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
                            "label":  "Provision for income taxes",
                            "totalLabel":  "Income tax provision",
                            "verboseLabel":  "Income tax provision"
                            }
                        }
                    },
                "localname":  "IncomeTaxExpenseBenefit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                    "http://organicell.com/role/IncomeTaxesDetails",
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxPolicyTextBlock":  {
                "auth_ref":  [
                    "r59",
                    "r355",
                    "r356",
                    "r362",
                    "r363",
                    "r367",
                    "r374"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
                            "label":  "Income Taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance":  {
                "auth_ref":  [
                    "r359"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
                            "label":  "Change in valuation allowance"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential":  {
                "auth_ref":  [
                    "r359"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  3.0,
                        "parentTag":  "bpsr_TotalIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
                            "label":  "Permanent differences"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate":  {
                "auth_ref":  [
                    "r359"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  1.0,
                        "parentTag":  "bpsr_TotalIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
                            "label":  "Tax at federal statutory rate"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxReconciliationOtherAdjustments":  {
                "auth_ref":  [
                    "r359"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  4.0,
                        "parentTag":  "bpsr_TotalIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
                            "label":  "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
                            "verboseLabel":  "Other"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationOtherAdjustments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes":  {
                "auth_ref":  [
                    "r359"
                    ],
                "calculation":  {
                    "http://organicell.com/role/IncomeTaxesDetails1":  {
                        "order":  2.0,
                        "parentTag":  "bpsr_TotalIncomeTaxExpenseBenefit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
                            "label":  "State taxes, net of federal benefit"
                            }
                        }
                    },
                "localname":  "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncomeTaxesPaid":  {
                "auth_ref":  [
                    "r88",
                    "r96"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
                            "label":  "Cash paid for taxes"
                            }
                        }
                    },
                "localname":  "IncomeTaxesPaid",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  6.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.",
                            "label":  "Increase (Decrease) in Accounts and Other Receivables",
                            "negatedLabel":  "Accounts receivable, net of allowance for bad debts"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsAndOtherReceivables",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
                            "label":  "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
                            "verboseLabel":  "Accounts payable and accrued expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInAccountsReceivable":  {
                "auth_ref":  [
                    "r91"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
                            "label":  "Increase (Decrease) in Accounts Receivable",
                            "negatedLabel":  "Accounts receivable"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInAccountsReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInContractWithCustomerLiability":  {
                "auth_ref":  [
                    "r91",
                    "r458"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  12.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
                            "label":  "Increase (Decrease) in Contract with Customer, Liability",
                            "verboseLabel":  "Deferred revenue"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInContractWithCustomerLiability",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInInventories":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  8.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
                            "label":  "Increase (Decrease) in Inventories",
                            "negatedLabel":  "Inventories"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInInventories",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Changes in operating assets and liabilities:"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInOperatingCapitalAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_IncreaseDecreaseInPrepaidExpense":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
                            "label":  "Increase (Decrease) in Prepaid Expense",
                            "negatedLabel":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInPrepaidExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_IncreaseDecreaseInSecurityDeposits":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  11.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The increase (decrease) during the reporting period in security deposits.",
                            "label":  "Increase (Decrease) in Security Deposits",
                            "verboseLabel":  "Security deposits"
                            }
                        }
                    },
                "localname":  "IncreaseDecreaseInSecurityDeposits",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpense":  {
                "auth_ref":  [
                    "r63",
                    "r163",
                    "r415",
                    "r417",
                    "r484"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the cost of borrowed funds accounted for as interest expense.",
                            "label":  "Interest expense",
                            "negatedLabel":  "Interest expense"
                            }
                        }
                    },
                "localname":  "InterestExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestExpenseOther":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of interest expense classified as other.",
                            "label":  "Interest expense on conversion of Funding Facility"
                            }
                        }
                    },
                "localname":  "InterestExpenseOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPaidNet":  {
                "auth_ref":  [
                    "r85",
                    "r87",
                    "r96"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity.  Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
                            "label":  "Cash paid for interest"
                            }
                        }
                    },
                "localname":  "InterestPaidNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InterestPayableCurrent":  {
                "auth_ref":  [
                    "r46"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid.  Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
                            "label":  "Accrued interest"
                            }
                        }
                    },
                "localname":  "InterestPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryDisclosureAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Inventory Disclosure [Abstract]"
                            }
                        }
                    },
                "localname":  "InventoryDisclosureAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InventoryDisclosureTextBlock":  {
                "auth_ref":  [
                    "r202"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for inventory.  Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
                            "label":  "INVENTORIES"
                            }
                        }
                    },
                "localname":  "InventoryDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/Inventories"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InventoryFinishedGoodsNetOfReserves":  {
                "auth_ref":  [
                    "r34",
                    "r201"
                    ],
                "calculation":  {
                    "http://organicell.com/role/InventoriesDetails":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
                            "label":  "Finished goods"
                            }
                        }
                    },
                "localname":  "InventoryFinishedGoodsNetOfReserves",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/InventoriesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryNet":  {
                "auth_ref":  [
                    "r8",
                    "r38",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        },
                    "http://organicell.com/role/InventoriesDetails":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
                            "label":  "Inventories",
                            "totalLabel":  "Total inventories"
                            }
                        }
                    },
                "localname":  "InventoryNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/InventoriesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryPolicyTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r36",
                    "r102",
                    "r139",
                    "r197",
                    "r199",
                    "r202",
                    "r459"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
                            "label":  "Inventory"
                            }
                        }
                    },
                "localname":  "InventoryPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves":  {
                "auth_ref":  [
                    "r38",
                    "r201"
                    ],
                "calculation":  {
                    "http://organicell.com/role/InventoriesDetails":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_InventoryNet",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.  This amount is net of valuation reserves and adjustments.",
                            "label":  "Raw materials and supplies"
                            }
                        }
                    },
                "localname":  "InventoryRawMaterialsAndSuppliesNetOfReserves",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/InventoriesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryValuationReserves":  {
                "auth_ref":  [
                    "r38",
                    "r200"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of valuation reserve for inventory.",
                            "label":  "Inventory Reserve"
                            }
                        }
                    },
                "localname":  "InventoryValuationReserves",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InventoryWriteDown":  {
                "auth_ref":  [
                    "r198"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
                            "label":  "Write-off of inventory"
                            }
                        }
                    },
                "localname":  "InventoryWriteDown",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_InvestmentTypeAxis":  {
                "auth_ref":  [
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r527",
                    "r528",
                    "r529",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of investments.",
                            "label":  "Investment Type [Axis]"
                            }
                        }
                    },
                "localname":  "InvestmentTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_InvestmentTypeCategorizationMember":  {
                "auth_ref":  [
                    "r517",
                    "r518",
                    "r519",
                    "r520",
                    "r521",
                    "r522",
                    "r523",
                    "r524",
                    "r525",
                    "r526",
                    "r527",
                    "r528",
                    "r529",
                    "r530",
                    "r531"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Asset obtained to generate income or appreciate in value."
                            }
                        }
                    },
                "localname":  "InvestmentTypeCategorizationMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_Investments":  {
                "auth_ref":  [
                    "r497"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all investments.",
                            "label":  "Investment"
                            }
                        }
                    },
                "localname":  "Investments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseAndRentalExpense":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
                            "label":  "Rent expenses"
                            }
                        }
                    },
                "localname":  "LeaseAndRentalExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseCost":  {
                "auth_ref":  [
                    "r430",
                    "r432"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lease cost recognized by lessee for lease contract.",
                            "label":  "Lease"
                            }
                        }
                    },
                "localname":  "LeaseCost",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LeaseholdImprovementsMember":  {
                "auth_ref":  [
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Additions or improvements to assets held under a lease arrangement.",
                            "label":  "Leasehold Improvements [Member]"
                            }
                        }
                    },
                "localname":  "LeaseholdImprovementsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_LegalFees":  {
                "auth_ref":  [
                    "r73"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
                            "label":  "Unpaid consulting fees",
                            "terseLabel":  "Legal Fees",
                            "verboseLabel":  "Legal fees"
                            }
                        }
                    },
                "localname":  "LegalFees",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeFinanceLeaseDiscountRate":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discount rate used by lessee to determine present value of finance lease payments.",
                            "label":  "Annual interest rate"
                            }
                        }
                    },
                "localname":  "LesseeFinanceLeaseDiscountRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_LesseeOperatingLeaseDiscountRate":  {
                "auth_ref":  [
                    "r427"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discount rate used by lessee to determine present value of operating lease payments.",
                            "label":  "Borrowing rate"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseDiscountRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails1":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid",
                            "totalLabel":  "Total undiscounted operating lease payments"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails1":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year One",
                            "verboseLabel":  "2022"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails1":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Three",
                            "verboseLabel":  "2024"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo":  {
                "auth_ref":  [
                    "r431"
                    ],
                "calculation":  {
                    "http://organicell.com/role/LeaseObligationsDetails1":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year.  Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
                            "label":  "Lessee, Operating Lease, Liability, to be Paid, Year Two",
                            "verboseLabel":  "2023"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LesseeOperatingLeasesTextBlock":  {
                "auth_ref":  [
                    "r433"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for operating leases of lessee.  Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
                            "label":  "LEASE OBLIGATIONS"
                            }
                        }
                    },
                "localname":  "LesseeOperatingLeasesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligations"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_Liabilities":  {
                "auth_ref":  [
                    "r45",
                    "r109",
                    "r171",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r390",
                    "r391",
                    "r392",
                    "r406",
                    "r445",
                    "r446"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized.  Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
                            "label":  "Liabilities",
                            "totalLabel":  "Total Liabilities"
                            }
                        }
                    },
                "localname":  "Liabilities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquity":  {
                "auth_ref":  [
                    "r33",
                    "r109",
                    "r193",
                    "r406",
                    "r447",
                    "r479",
                    "r494"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
                            "label":  "Liabilities and Equity",
                            "totalLabel":  "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesAndStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT"
                            }
                        }
                    },
                "localname":  "LiabilitiesAndStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesCurrent":  {
                "auth_ref":  [
                    "r11",
                    "r47",
                    "r109",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r390",
                    "r391",
                    "r392",
                    "r406",
                    "r445",
                    "r446",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
                            "label":  "Liabilities, Current",
                            "totalLabel":  "Total Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LiabilitiesCurrentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Current Liabilities"
                            }
                        }
                    },
                "localname":  "LiabilitiesCurrentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent":  {
                "auth_ref":  [
                    "r1",
                    "r2",
                    "r3",
                    "r4",
                    "r5",
                    "r206",
                    "r211"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  9.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
                            "label":  "Liabilities attributable to discontinued operations",
                            "verboseLabel":  "Liabilities, total"
                            }
                        }
                    },
                "localname":  "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCredit":  {
                "auth_ref":  [
                    "r22",
                    "r478",
                    "r489"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount.  Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.  Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
                            "label":  "Line of credit"
                            }
                        }
                    },
                "localname":  "LineOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LineOfCreditFacilityPeriodicPayment":  {
                "auth_ref":  [
                    "r42"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of the required periodic payments of both interest and principal.",
                            "label":  "Line of Credit Facility, Periodic Payment"
                            }
                        }
                    },
                "localname":  "LineOfCreditFacilityPeriodicPayment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongTermDebtCurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current.  Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper.  Excludes capital lease obligations.",
                            "label":  "Promissory note discount"
                            }
                        }
                    },
                "localname":  "LongTermDebtCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_LongtermDebtTypeAxis":  {
                "auth_ref":  [
                    "r50"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-term debt.",
                            "label":  "Long-Term Debt, Type [Axis]"
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_LongtermDebtTypeDomain":  {
                "auth_ref":  [
                    "r50",
                    "r228"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.  These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
                            }
                        }
                    },
                "localname":  "LongtermDebtTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ManagementFeePayable":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.",
                            "label":  "Unpiad professional fees"
                            }
                        }
                    },
                "localname":  "ManagementFeePayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_MarketingExpense":  {
                "auth_ref":  [
                    "r74"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services.  Costs of public relations and corporate promotions are typically considered to be marketing costs.",
                            "label":  "Marketing services"
                            }
                        }
                    },
                "localname":  "MarketingExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NatureOfOperations":  {
                "auth_ref":  [
                    "r145",
                    "r156"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings.  For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
                            "label":  "ORGANIZATION AND DESCRIPTION OF BUSINESS"
                            }
                        }
                    },
                "localname":  "NatureOfOperations",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/OrganizationAndDescriptionOfBusiness"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivities":  {
                "auth_ref":  [
                    "r86"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from financing activities, including discontinued operations.  Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
                            "label":  "Net Cash Provided by (Used in) Financing Activities",
                            "totalLabel":  "Net cash provided by financing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CASH FLOWS FROM FINANCING ACTIVITIES"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInFinancingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivities":  {
                "auth_ref":  [
                    "r86"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from investing activities, including discontinued operations.  Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
                            "label":  "Net Cash Provided by (Used in) Investing Activities",
                            "totalLabel":  "Net cash used in investing activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CASH FLOWS FROM INVESTING ACTIVITIES"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInInvestingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivities":  {
                "auth_ref":  [
                    "r86",
                    "r90",
                    "r93"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                        "weight":  1.0
                        }
                    },
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow (outflow) from operating activities, including discontinued operations.  Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
                            "label":  "Net Cash Provided by (Used in) Operating Activities",
                            "totalLabel":  "Net cash used in operating activities"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivities",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "CASH FLOWS FROM OPERATING ACTIVITIES"
                            }
                        }
                    },
                "localname":  "NetCashProvidedByUsedInOperatingActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_NetIncomeLoss":  {
                "auth_ref":  [
                    "r5",
                    "r57",
                    "r58",
                    "r62",
                    "r66",
                    "r93",
                    "r109",
                    "r122",
                    "r124",
                    "r125",
                    "r126",
                    "r127",
                    "r129",
                    "r130",
                    "r134",
                    "r166",
                    "r169",
                    "r172",
                    "r175",
                    "r178",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r400",
                    "r406",
                    "r483",
                    "r499"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        },
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  null,
                        "parentTag":  null,
                        "root":  true,
                        "weight":  null
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
                            "label":  "Net loss",
                            "negatedLabel":  "Net losses",
                            "totalLabel":  "Net loss"
                            }
                        }
                    },
                "localname":  "NetIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                    "http://organicell.com/role/GoingConcernDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NotesPayableCurrent":  {
                "auth_ref":  [
                    "r44"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
                            "label":  "Notes payable"
                            }
                        }
                    },
                "localname":  "NotesPayableCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_NumberOfOperatingSegments":  {
                "auth_ref":  [
                    "r158"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of operating segments.  An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available.  An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
                            "label":  "Number of operating segments"
                            }
                        }
                    },
                "localname":  "NumberOfOperatingSegments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SegmentInformationDetailsNarrative"
                    ],
                "xbrltype":  "integerItemType"
                },
            "us-gaap_OperatingIncomeLoss":  {
                "auth_ref":  [
                    "r166",
                    "r169",
                    "r172",
                    "r175",
                    "r178"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The net result for the period of deducting operating expenses from operating revenues.",
                            "label":  "Operating Income (Loss)",
                            "negatedLabel":  "Loss from operations",
                            "totalLabel":  "Loss from operations"
                            }
                        }
                    },
                "localname":  "OperatingIncomeLoss",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations",
                    "http://organicell.com/role/GoingConcernDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseExpense":  {
                "auth_ref":  [
                    "r425"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating lease expense.  Excludes sublease income.",
                            "label":  "Lease expense"
                            }
                        }
                    },
                "localname":  "OperatingLeaseExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock":  {
                "auth_ref":  [
                    "r140",
                    "r434"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of components of income from operating lease.",
                            "label":  "Schedule of Operating Lease"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLeaseIncomeTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_OperatingLeaseLiability":  {
                "auth_ref":  [
                    "r424"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease.",
                            "label":  "Present value of operating lease liabilities",
                            "verboseLabel":  "Operating lease obligation"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiability",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetails1",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityCurrent":  {
                "auth_ref":  [
                    "r424"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  7.0,
                        "parentTag":  "us-gaap_LiabilitiesCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
                            "label":  "Operating lease obligations"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseLiabilityNoncurrent":  {
                "auth_ref":  [
                    "r424"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Liabilities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
                            "label":  "Long term operating lease obligations"
                            }
                        }
                    },
                "localname":  "OperatingLeaseLiabilityNoncurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasePayments":  {
                "auth_ref":  [
                    "r426",
                    "r428"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
                            "label":  "Monthly payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasePayments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense":  {
                "auth_ref":  [
                    "r92"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of amortization expense for right-of-use asset from operating lease.",
                            "label":  "Operating lease \u2013 right of use assets"
                            }
                        }
                    },
                "localname":  "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1":  {
                "auth_ref":  [
                    "r429",
                    "r432"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Operating leases"
                            }
                        }
                    },
                "localname":  "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_OperatingLeasesFutureMinimumPaymentsDue":  {
                "auth_ref":  [
                    "r420",
                    "r422"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
                            "label":  "Minimum monthly lease payments"
                            }
                        }
                    },
                "localname":  "OperatingLeasesFutureMinimumPaymentsDue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLeasesRentExpenseNet":  {
                "auth_ref":  [
                    "r421"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
                            "label":  "Monthly rent expense"
                            }
                        }
                    },
                "localname":  "OperatingLeasesRentExpenseNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OperatingLossCarryforwards":  {
                "auth_ref":  [
                    "r369"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
                            "label":  "Net operating loss carryforward"
                            }
                        }
                    },
                "localname":  "OperatingLossCarryforwards",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
                            }
                        }
                    },
                "localname":  "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherAssets":  {
                "auth_ref":  [
                    "r16",
                    "r475",
                    "r490"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of assets classified as other.",
                            "label":  "Other assets \u2013 right of use"
                            }
                        }
                    },
                "localname":  "OtherAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCommitment":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Minimum amount of other commitment not otherwise specified in the taxonomy.  Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
                            "label":  "Other Commitment",
                            "verboseLabel":  "Commitment fee"
                            }
                        }
                    },
                "localname":  "OtherCommitment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_OtherCommitmentsAxis":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of other commitment.",
                            "label":  "Other Commitments [Axis]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsDomain":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Other future obligation."
                            }
                        }
                    },
                "localname":  "OtherCommitmentsDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_OtherCommitmentsLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Other Commitments [Line Items]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherCommitmentsTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about obligations resulting from other commitments.",
                            "label":  "Other Commitments [Table]"
                            }
                        }
                    },
                "localname":  "OtherCommitmentsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherIncomeAndExpensesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Other income (expense)"
                            }
                        }
                    },
                "localname":  "OtherIncomeAndExpensesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_OtherNonoperatingIncomeExpense":  {
                "auth_ref":  [
                    "r76"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of income (expense) related to nonoperating activities, classified as other.",
                            "label":  "Other"
                            }
                        }
                    },
                "localname":  "OtherNonoperatingIncomeExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForBrokerageFees":  {
                "auth_ref":  [
                    "r89"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid for brokerage fees during the current period.  This element is intended to represent the brokerage fees paid by and between financial industry participants.",
                            "label":  "Brokerage fees"
                            }
                        }
                    },
                "localname":  "PaymentsForBrokerageFees",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForLeasingCosts":  {
                "auth_ref":  [
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for costs that are essential to originate the lease and would not otherwise have been incurred without the lease agreement.  Amount includes, but is not limited to, cash outflows to evaluate the lessee's credit condition, guarantees, and collateral and cash outflows for costs incurred in negotiating, processing, and executing the lease agreement.",
                            "label":  "Payments for Leasing Costs",
                            "negatedLabel":  "Payments on finance lease"
                            }
                        }
                    },
                "localname":  "PaymentsForLeasingCosts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForLegalSettlements":  {
                "auth_ref":  [
                    "r89"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
                            "label":  "Settlement of Litigation"
                            }
                        }
                    },
                "localname":  "PaymentsForLegalSettlements",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsForRent":  {
                "auth_ref":  [
                    "r89"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash payments to lessor's for use of assets under operating leases.",
                            "label":  "Payment for certain expenses"
                            }
                        }
                    },
                "localname":  "PaymentsForRent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquireNotesReceivable":  {
                "auth_ref":  [
                    "r79"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date.  Such amount may include accrued interest receivable in accordance with the terms of the note.  The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.",
                            "label":  "Payments for notes receivable"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquireNotesReceivable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment":  {
                "auth_ref":  [
                    "r80"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInInvestingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
                            "label":  "Payments to Acquire Property, Plant, and Equipment",
                            "negatedLabel":  "Purchase of fixed assets"
                            }
                        }
                    },
                "localname":  "PaymentsToAcquirePropertyPlantAndEquipment",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PlanNameAxis":  {
                "auth_ref":  [
                    "r314",
                    "r315",
                    "r316",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322",
                    "r323",
                    "r324",
                    "r325",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by plan name for share-based payment arrangement.",
                            "label":  "Plan Name [Axis]"
                            }
                        }
                    },
                "localname":  "PlanNameAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PlanNameDomain":  {
                "auth_ref":  [
                    "r314",
                    "r315",
                    "r316",
                    "r318",
                    "r319",
                    "r320",
                    "r321",
                    "r322",
                    "r323",
                    "r324",
                    "r325",
                    "r327",
                    "r328",
                    "r329",
                    "r330",
                    "r331",
                    "r332",
                    "r333",
                    "r334",
                    "r335",
                    "r336",
                    "r340",
                    "r341",
                    "r342",
                    "r343",
                    "r344"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Plan name for share-based payment arrangement."
                            }
                        }
                    },
                "localname":  "PlanNameDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PlantConstructionUsingIntermediaryPolicy":  {
                "auth_ref":  [
                    "r539"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for a utility company's accounting treatment when it uses an intermediary for plant construction.  The intermediary's work in progress is included by the utility in an appropriate caption under the utility plant.  The related debt is included in long term liabilities and disclosed on the balance sheet or in a note.",
                            "label":  "Construction in Progress"
                            }
                        }
                    },
                "localname":  "PlantConstructionUsingIntermediaryPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PreferredStockParOrStatedValuePerShare":  {
                "auth_ref":  [
                    "r26",
                    "r279"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
                            "label":  "Preferred stock, par value"
                            }
                        }
                    },
                "localname":  "PreferredStockParOrStatedValuePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_PreferredStockSharesAuthorized":  {
                "auth_ref":  [
                    "r26"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
                            "label":  "Preferred stock, shares authorized"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesAuthorized",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PreferredStockSharesOutstanding":  {
                "auth_ref":  [
                    "r26"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders.  Does not include preferred shares that have been repurchased.",
                            "label":  "Preferred stock, shares outstanding"
                            }
                        }
                    },
                "localname":  "PreferredStockSharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_PrepaidExpenseCurrent":  {
                "auth_ref":  [
                    "r9",
                    "r39",
                    "r203",
                    "r204"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_AssetsCurrent",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
                            "label":  "Prepaid expenses"
                            }
                        }
                    },
                "localname":  "PrepaidExpenseCurrent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromContributionsFromParent":  {
                "auth_ref":  [
                    "r83"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.",
                            "label":  "Capital contribution"
                            }
                        }
                    },
                "localname":  "ProceedsFromContributionsFromParent",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromConvertibleDebt":  {
                "auth_ref":  [
                    "r82"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
                            "label":  "Proceeds from issuance of Promissory Note"
                            }
                        }
                    },
                "localname":  "ProceedsFromConvertibleDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOfCommonStock":  {
                "auth_ref":  [
                    "r81"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the additional capital contribution to the entity.",
                            "label":  "Proceeds from sale of common stock",
                            "verboseLabel":  "Common stock shares converted"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOfCommonStock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromIssuanceOrSaleOfEquity":  {
                "auth_ref":  [
                    "r81"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.",
                            "label":  "Proceeds from stock issued"
                            }
                        }
                    },
                "localname":  "ProceedsFromIssuanceOrSaleOfEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromNotesPayable":  {
                "auth_ref":  [
                    "r82"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
                            "label":  "Proceeds from issuance of notes payable",
                            "verboseLabel":  "Proceeds from note payble"
                            }
                        }
                    },
                "localname":  "ProceedsFromNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromRelatedPartyDebt":  {
                "auth_ref":  [
                    "r82"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.  Alternate caption:  Proceeds from Advances from Affiliates.",
                            "label":  "Proceeds from related party debt"
                            }
                        }
                    },
                "localname":  "ProceedsFromRelatedPartyDebt",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProceedsFromSaleOfOtherProductiveAssets":  {
                "auth_ref":  [
                    "r78"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash inflow from the sale of tangible or intangible assets used to produce goods or deliver services, classified as other.",
                            "label":  "Proceed from sale of products"
                            }
                        }
                    },
                "localname":  "ProceedsFromSaleOfOtherProductiveAssets",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ProductInformationLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Product Information [Line Items]"
                            }
                        }
                    },
                "localname":  "ProductInformationLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ProfessionalFees":  {
                "auth_ref":  [
                    "r514",
                    "r516"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A fee charged for services from professionals such as doctors, lawyers and accountants.  The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
                            "label":  "Consulting fees"
                            }
                        }
                    },
                "localname":  "ProfessionalFees",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Property, Plant and Equipment [Abstract]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentByTypeAxis":  {
                "auth_ref":  [
                    "r210"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
                            "label":  "Long-Lived Tangible Asset [Axis]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentByTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock":  {
                "auth_ref":  [
                    "r212",
                    "r534",
                    "r535",
                    "r536"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "PROPERTY AND EQUIPMENT"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipment"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentGross":  {
                "auth_ref":  [
                    "r14",
                    "r208"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property and equipment, gross"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Property, Plant and Equipment [Line Items]"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentNet":  {
                "auth_ref":  [
                    "r210",
                    "r447",
                    "r486",
                    "r495"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
                            "label":  "Property and equipment, net",
                            "verboseLabel":  "Total property and equipment, net"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentNet",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentOther":  {
                "auth_ref":  [
                    "r210"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.",
                            "label":  "Payment to acquire"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock":  {
                "auth_ref":  [
                    "r210",
                    "r534",
                    "r535"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale.  Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
                            "label":  "Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTextBlock":  {
                "auth_ref":  [
                    "r210"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Schedule of Property and Equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentTypeDomain":  {
                "auth_ref":  [
                    "r208"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.  Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_PropertyPlantAndEquipmentUsefulLife":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.  Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
                            "label":  "Property, plant and equipment, estimated useful lives",
                            "verboseLabel":  "Estimated useful lives of leased equipment"
                            }
                        }
                    },
                "localname":  "PropertyPlantAndEquipmentUsefulLife",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_ProvisionForDoubtfulAccounts":  {
                "auth_ref":  [
                    "r68",
                    "r195"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
                            "label":  "Accounts Receivable, Credit Loss Expense (Reversal)",
                            "verboseLabel":  "Bad debt expense"
                            }
                        }
                    },
                "localname":  "ProvisionForDoubtfulAccounts",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ReceivablesPolicyTextBlock":  {
                "auth_ref":  [
                    "r188",
                    "r190",
                    "r191",
                    "r192"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for receivable.  Includes, but is not limited to, accounts receivable and financing receivable.",
                            "label":  "Accounts Receivable"
                            }
                        }
                    },
                "localname":  "ReceivablesPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RelatedPartyDomain":  {
                "auth_ref":  [
                    "r310",
                    "r438",
                    "r439"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
                            }
                        }
                    },
                "localname":  "RelatedPartyDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionAxis":  {
                "auth_ref":  [
                    "r310",
                    "r438",
                    "r439",
                    "r442"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party transaction.",
                            "label":  "Related Party Transaction [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionDomain":  {
                "auth_ref":  [
                    "r310"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Transaction between related party."
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RelatedPartyTransactionLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Related Party Transaction [Line Items]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Related Party Transactions [Abstract]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis":  {
                "auth_ref":  [
                    "r310",
                    "r438",
                    "r442",
                    "r462",
                    "r463",
                    "r464",
                    "r465",
                    "r466",
                    "r467",
                    "r468",
                    "r469",
                    "r470",
                    "r471",
                    "r472",
                    "r473"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by type of related party.  Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families.  It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
                            "label":  "Related Party [Axis]"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsByRelatedPartyAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RelatedPartyTransactionsDisclosureTextBlock":  {
                "auth_ref":  [
                    "r436",
                    "r437",
                    "r439",
                    "r443",
                    "r444"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "RELATED PARTY TRANSACTIONS"
                            }
                        }
                    },
                "localname":  "RelatedPartyTransactionsDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactions"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RepaymentOfNotesReceivableFromRelatedParties":  {
                "auth_ref":  [
                    "r77"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash inflow from a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.",
                            "label":  "Repayment of promissory note"
                            }
                        }
                    },
                "localname":  "RepaymentOfNotesReceivableFromRelatedParties",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfLinesOfCredit":  {
                "auth_ref":  [
                    "r84",
                    "r108"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
                            "label":  "Repayment of line of credit"
                            }
                        }
                    },
                "localname":  "RepaymentsOfLinesOfCredit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RepaymentsOfNotesPayable":  {
                "auth_ref":  [
                    "r84"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInFinancingActivities",
                        "weight":  -1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
                            "label":  "Repayments of Notes Payable",
                            "negatedLabel":  "Repayments of notes payable"
                            }
                        }
                    },
                "localname":  "RepaymentsOfNotesPayable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpense":  {
                "auth_ref":  [
                    "r354",
                    "r460",
                    "r540"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
                            "label":  "Research and Development Expense"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpense",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ResearchAndDevelopmentExpensePolicy":  {
                "auth_ref":  [
                    "r354"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
                            "label":  "Research and Development Costs"
                            }
                        }
                    },
                "localname":  "ResearchAndDevelopmentExpensePolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RestructuringAndRelatedActivitiesAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Restructuring and Related Activities [Abstract]"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedActivitiesAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock":  {
                "auth_ref":  [
                    "r215",
                    "r216",
                    "r217",
                    "r218",
                    "r219"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for restructuring and related activities.  Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
                            "label":  "RESTRUCTURING"
                            }
                        }
                    },
                "localname":  "RestructuringAndRelatedActivitiesDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/Restructuring"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_RetainedEarningsAccumulatedDeficit":  {
                "auth_ref":  [
                    "r30",
                    "r304",
                    "r447",
                    "r493",
                    "r508",
                    "r509"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  3.0,
                        "parentTag":  "us-gaap_StockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Accumulated deficit",
                            "negatedLabel":  "Accumulated deficit"
                            }
                        }
                    },
                "localname":  "RetainedEarningsAccumulatedDeficit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/GoingConcernDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RetainedEarningsMember":  {
                "auth_ref":  [
                    "r0",
                    "r119",
                    "r120",
                    "r121",
                    "r123",
                    "r128",
                    "r130",
                    "r194",
                    "r348",
                    "r349",
                    "r350",
                    "r375",
                    "r376",
                    "r399",
                    "r505",
                    "r507"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
                            "label":  "Retained Earnings [Member]"
                            }
                        }
                    },
                "localname":  "RetainedEarningsMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_RevenueFromRelatedParties":  {
                "auth_ref":  [
                    "r70",
                    "r232",
                    "r234",
                    "r235",
                    "r239",
                    "r240",
                    "r241",
                    "r515"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
                            "label":  "Revenue from related parties"
                            }
                        }
                    },
                "localname":  "RevenueFromRelatedParties",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_RevenueRecognitionPolicyTextBlock":  {
                "auth_ref":  [
                    "r103",
                    "r104"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for revenue.  Includes revenue from contract with customer and from other sources.",
                            "label":  "Revenue Recognition"
                            }
                        }
                    },
                "localname":  "RevenueRecognitionPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_Revenues":  {
                "auth_ref":  [
                    "r64",
                    "r109",
                    "r161",
                    "r162",
                    "r168",
                    "r173",
                    "r174",
                    "r180",
                    "r181",
                    "r183",
                    "r193",
                    "r229",
                    "r230",
                    "r231",
                    "r234",
                    "r235",
                    "r236",
                    "r237",
                    "r238",
                    "r240",
                    "r241",
                    "r406",
                    "r485"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations":  {
                        "order":  1.0,
                        "parentTag":  "us-gaap_GrossProfit",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process.  Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
                            "label":  "Revenues",
                            "verboseLabel":  "Monthly Revenues"
                            }
                        }
                    },
                "localname":  "Revenues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetails",
                    "http://organicell.com/role/ConsolidatedStatementsOfOperations"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SalariesAndWages":  {
                "auth_ref":  [
                    "r67"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of expense for salary and wage arising from service rendered by nonofficer employee.  Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.",
                            "label":  "Salary amounts",
                            "verboseLabel":  "Base salary"
                            }
                        }
                    },
                "localname":  "SalariesAndWages",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleLeasebackTransactionImputedInterestRate":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The financing cost related to leases that have been recorded under the deposit method, as a financing or as a capital leases in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.",
                            "label":  "Sale of interest rate",
                            "verboseLabel":  "Annual interest rate"
                            }
                        }
                    },
                "localname":  "SaleLeasebackTransactionImputedInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_SaleLeasebackTransactionMonthlyRentalPayments":  {
                "auth_ref":  [
                    "r423"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.",
                            "label":  "Sale Leaseback Transaction, Monthly Rental Payments",
                            "verboseLabel":  "Monthly payments"
                            }
                        }
                    },
                "localname":  "SaleLeasebackTransactionMonthlyRentalPayments",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockConsiderationReceivedOnTransaction":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Cash received on stock transaction after deduction of issuance costs.",
                            "label":  "Sale of transaction",
                            "verboseLabel":  "Purchase price"
                            }
                        }
                    },
                "localname":  "SaleOfStockConsiderationReceivedOnTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
                            "label":  "Number of common stock sold",
                            "verboseLabel":  "Additional shares issued"
                            }
                        }
                    },
                "localname":  "SaleOfStockNumberOfSharesIssuedInTransaction",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SaleOfStockPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
                            "label":  "Sale of stock, price per share"
                            }
                        }
                    },
                "localname":  "SaleOfStockPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock":  {
                "auth_ref":  [
                    "r308"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
                            "label":  "Schedule of Employee Benefits"
                            }
                        }
                    },
                "localname":  "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfAssetRetirementObligationsTableTextBlock":  {
                "auth_ref":  [
                    "r213"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the carrying amount of a liability for asset retirement obligations.",
                            "label":  "Schedule of carrying amounts of the assets and liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfAssetRetirementObligationsTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable":  {
                "auth_ref":  [
                    "r388"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-ManagementAndConsultantsPerformanceStockPlan",
                    "http://organicell.com/role/CapitalStockDetails2",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock":  {
                "auth_ref":  [
                    "r374"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
                            "label":  "Schedule of consolidated provision for income taxes"
                            }
                        }
                    },
                "localname":  "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock":  {
                "auth_ref":  [
                    "r366"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
                            "label":  "Schedule of Deferred Tax assets and Liabilities"
                            }
                        }
                    },
                "localname":  "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock":  {
                "auth_ref":  [
                    "r110"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
                            "label":  "Schedule of Income before Income Taxes"
                            }
                        }
                    },
                "localname":  "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfInventoryCurrentTableTextBlock":  {
                "auth_ref":  [
                    "r12",
                    "r35",
                    "r36",
                    "r37"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
                            "label":  "Schedule of Inventories"
                            }
                        }
                    },
                "localname":  "ScheduleOfInventoryCurrentTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/InventoriesTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock":  {
                "auth_ref":  [
                    "r326"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Tabular disclosure of the changes in outstanding nonvested shares.",
                            "label":  "Schedule of Non vested Share Activity"
                            }
                        }
                    },
                "localname":  "ScheduleOfNonvestedShareActivityTableTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockTables"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ScheduleOfProductInformationTable":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing quantitative information concerning products or product lines by product or product line.",
                            "label":  "Schedule of Product Information [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfProductInformationTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable":  {
                "auth_ref":  [
                    "r210"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale.  Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
                            "label":  "Property, Plant and Equipment [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfPropertyPlantAndEquipmentTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/PropertyAndEquipmentDetails"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable":  {
                "auth_ref":  [
                    "r440",
                    "r442"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule of quantitative and qualitative information pertaining to related party transactions.  Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
                            "label":  "Schedule of Related Party Transactions, by Related Party [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable":  {
                "auth_ref":  [
                    "r347"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
                            "label":  "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfShortTermDebtTable":  {
                "auth_ref":  [
                    "r43"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance.  It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
                            "label":  "Schedule of Short-Term Debt [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfShortTermDebtTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ScheduleOfStockByClassTable":  {
                "auth_ref":  [
                    "r24",
                    "r26",
                    "r27",
                    "r106",
                    "r142",
                    "r143",
                    "r276",
                    "r277",
                    "r278",
                    "r279",
                    "r280",
                    "r281",
                    "r282",
                    "r284",
                    "r288",
                    "r294",
                    "r296",
                    "r297",
                    "r298",
                    "r299",
                    "r301",
                    "r302",
                    "r303",
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule detailing information related to equity by class of stock.  Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer.  It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
                            "label":  "Schedule of Stock by Class [Table]"
                            }
                        }
                    },
                "localname":  "ScheduleOfStockByClassTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SecurityDeposit":  {
                "auth_ref":  [
                    "r16"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  4.0,
                        "parentTag":  "us-gaap_Assets",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.",
                            "label":  "Security deposits",
                            "verboseLabel":  "Security deposit"
                            }
                        }
                    },
                "localname":  "SecurityDeposit",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SegmentReportingAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Segment Reporting [Abstract]"
                            }
                        }
                    },
                "localname":  "SegmentReportingAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SegmentReportingDisclosureTextBlock":  {
                "auth_ref":  [
                    "r157",
                    "r159",
                    "r160",
                    "r166",
                    "r167",
                    "r172",
                    "r176",
                    "r177",
                    "r178",
                    "r179",
                    "r180",
                    "r182",
                    "r183",
                    "r184"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for reporting segments including data and tables.  Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
                            "label":  "SEGMENT INFORMATION"
                            }
                        }
                    },
                "localname":  "SegmentReportingDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SegmentInformation"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensation":  {
                "auth_ref":  [
                    "r91"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows":  {
                        "order":  5.0,
                        "parentTag":  "us-gaap_NetCashProvidedByUsedInOperatingActivities",
                        "weight":  1.0
                        }
                    },
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of noncash expense for share-based payment arrangement.",
                            "label":  "Stock-based compensation",
                            "terseLabel":  "Stock-based compensation expense",
                            "verboseLabel":  "Stock based compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod":  {
                "auth_ref":  [
                    "r330"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
                            "label":  "Number of Non-Vested Shares, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod":  {
                "auth_ref":  [
                    "r331"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
                            "label":  "Number of Non-Vested Shares, Vested",
                            "negatedLabel":  "Number of Non-Vested Shares, Vested"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate":  {
                "auth_ref":  [
                    "r342"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
                            "label":  "Expected dividend rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate":  {
                "auth_ref":  [
                    "r341"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The estimated measure of the percentage by which a share price is expected to fluctuate during a period.  Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean.  The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period.  That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
                            "label":  "Expected stock volatility"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate":  {
                "auth_ref":  [
                    "r343"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
                            "label":  "Risk free interest rate"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "percentItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue":  {
                "auth_ref":  [
                    "r334"
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
                            "label":  "Aggregate Intrinsic Value, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod":  {
                "auth_ref":  [
                    "r321"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
                            "label":  "Number of Shares, Expired/Forfeited",
                            "negatedLabel":  "Number of Shares, Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r321"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price of options that were either forfeited or expired.",
                            "label":  "Weighted-average Exercise Price, Expired/Forfeited"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":  {
                "auth_ref":  [
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Gross number of share options (or share units) granted during the period.",
                            "label":  "Common stock granted",
                            "verboseLabel":  "Number of Shares, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":  {
                "auth_ref":  [
                    "r318",
                    "r319"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options outstanding, including both vested and non-vested options.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
                            "periodEndLabel":  "Number of Shares Outstanding ending balance",
                            "periodStartLabel":  "Number of Shares Outstanding beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r318",
                    "r319"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted-average Exercise Price Outstanding ending balance",
                            "periodStartLabel":  "Weighted-average Exercise Price Outstanding beginning balance"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
                            "label":  "Weighted-average Exercise Price, Exercised"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":  {
                "auth_ref":  [
                    "r322"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
                            "label":  "Weighted-average Exercise Price, Granted"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy":  {
                "auth_ref":  [
                    "r317",
                    "r338",
                    "r339",
                    "r340",
                    "r341",
                    "r344",
                    "r351",
                    "r353"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for award under share-based payment arrangement.  Includes, but is not limited to, methodology and assumption used in measuring cost.",
                            "label":  "Stock-Based Compensation"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationOptionAndIncentivePlansPolicy",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis":  {
                "auth_ref":  [
                    "r337"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by range of option prices pertaining to options granted.",
                            "label":  "Exercise Price Range [Axis]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain":  {
                "auth_ref":  [
                    "r345"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]"
                            }
                        }
                    },
                "localname":  "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails",
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails-MinimumPre-transactionPricePerShare",
                    "http://organicell.com/role/CapitalStockDetails1"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SharePrice":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Price of a single share of a number of saleable stocks of a company.",
                            "label":  "Share Price",
                            "verboseLabel":  "Share price"
                            }
                        }
                    },
                "localname":  "SharePrice",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding":  {
                "auth_ref":  [
                    ],
                "crdr":  "debit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Intrinsic value of outstanding award under share-based payment arrangement.  Excludes share and unit options.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding",
                            "periodEndLabel":  "Aggregate Intrinsic Value Outstanding ending balance",
                            "periodStartLabel":  "Aggregate Intrinsic Value Outstanding beginning balance"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1":  {
                "auth_ref":  [
                    "r340"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
                            "label":  "Term"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of non-vested options outstanding.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
                            "periodEndLabel":  "Number of Nonvested Shares, Outstanding at ending",
                            "periodStartLabel":  "Number of Nonvested Shares, Outstanding at beginning"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average grant-date fair value of non-vested options outstanding.",
                            "label":  "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
                            "periodEndLabel":  "Weighted-Average Grant Date Value, Outstanding at ending",
                            "periodStartLabel":  "Weighted-Average Grant Date Value, Outstanding at beginning"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2":  {
                "auth_ref":  [
                    "r335"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
                            "label":  "Remaining Contractual Term (years) Outstanding beginning balance"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "durationItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of options vested.",
                            "label":  "Shares vested"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Weighted average grant-date fair value of options vested.",
                            "label":  "Weighted-Average Grant Date Value, Granted"
                            }
                        }
                    },
                "localname":  "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-UnvestedEquityInstrumentsOutstanding",
                    "http://organicell.com/role/CapitalStockDetails3"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesIssued":  {
                "auth_ref":  [
                    "r296"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
                            "label":  "Shares issued"
                            }
                        }
                    },
                "localname":  "SharesIssued",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_SharesIssuedPricePerShare":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share or per unit amount of equity securities issued.",
                            "label":  "Shares issued, price per share",
                            "verboseLabel":  "Share price"
                            }
                        }
                    },
                "localname":  "SharesIssuedPricePerShare",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_SharesOutstanding":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued which are neither cancelled nor held in the treasury.",
                            "label":  "Shares, Outstanding",
                            "periodEndLabel":  "Ending balance, shares",
                            "periodStartLabel":  "Beginning balance, shares"
                            }
                        }
                    },
                "localname":  "SharesOutstanding",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_ShortTermDebtLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Short-Term Debt [Line Items]"
                            }
                        }
                    },
                "localname":  "ShortTermDebtLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/NotesPayableDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SignificantAccountingPoliciesTextBlock":  {
                "auth_ref":  [
                    "r101",
                    "r118"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for all significant accounting policies of the reporting entity.",
                            "label":  "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
                            }
                        }
                    },
                "localname":  "SignificantAccountingPoliciesTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_StatementClassOfStockAxis":  {
                "auth_ref":  [
                    "r24",
                    "r26",
                    "r27",
                    "r106",
                    "r109",
                    "r131",
                    "r132",
                    "r133",
                    "r135",
                    "r136",
                    "r142",
                    "r143",
                    "r144",
                    "r193",
                    "r229",
                    "r234",
                    "r235",
                    "r236",
                    "r240",
                    "r241",
                    "r279",
                    "r280",
                    "r284",
                    "r288",
                    "r296",
                    "r406",
                    "r557"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by the different classes of stock of the entity.",
                            "label":  "Class of Stock [Axis]"
                            }
                        }
                    },
                "localname":  "StatementClassOfStockAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementEquityComponentsAxis":  {
                "auth_ref":  [
                    "r0",
                    "r53",
                    "r60",
                    "r61",
                    "r62",
                    "r119",
                    "r120",
                    "r121",
                    "r123",
                    "r128",
                    "r130",
                    "r141",
                    "r194",
                    "r296",
                    "r304",
                    "r348",
                    "r349",
                    "r350",
                    "r375",
                    "r376",
                    "r399",
                    "r408",
                    "r409",
                    "r410",
                    "r411",
                    "r412",
                    "r413",
                    "r435",
                    "r505",
                    "r506",
                    "r507"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by component of equity.",
                            "label":  "Equity Components [Axis]"
                            }
                        }
                    },
                "localname":  "StatementEquityComponentsAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Line items represent financial concepts included in a table.  These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
                            "label":  "Statement [Line Items]"
                            }
                        }
                    },
                "localname":  "StatementLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfCashFlowsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Cash Flows [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfCashFlowsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfFinancialPositionAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Statement of Financial Position [Abstract]"
                            }
                        }
                    },
                "localname":  "StatementOfFinancialPositionAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementOfStockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "localname":  "StatementOfStockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StatementTable":  {
                "auth_ref":  [
                    "r119",
                    "r120",
                    "r121",
                    "r141",
                    "r461"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
                            "label":  "Statement [Table]"
                            }
                        }
                    },
                "localname":  "StatementTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/LiabilitiesAttributableToDiscontinuedOperationsDetails",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation":  {
                "auth_ref":  [
                    "r313",
                    "r352"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares granted under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Stock granted of period value"
                            }
                        }
                    },
                "localname":  "StockGrantedDuringPeriodValueSharebasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued in lieu of cash for services contributed to the entity.  Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
                            "label":  "Stock issued for future services, shares",
                            "verboseLabel":  "Stock issued for services, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesNewIssues":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r296",
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of new stock issued during the period.",
                            "label":  "Common stock issued as commitment fee for Promissory Note, Shares",
                            "terseLabel":  "Number of shares issued",
                            "verboseLabel":  "Issuance of common stock"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesOther":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares of stock issued attributable to transactions classified as other.",
                            "label":  "Shares",
                            "verboseLabel":  "Number of common stock issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesOther",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetails-DebtAndorEquityFinancings",
                    "http://organicell.com/role/CapitalStockDetails1",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r296",
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
                            "label":  "Number of restricted shares issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r296",
                    "r304"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number, after forfeiture, of shares or units issued under share-based payment arrangement.  Excludes shares or units issued under employee stock ownership plan (ESOP).",
                            "label":  "Stock based compensation, shares",
                            "verboseLabel":  "Shares issued, shares based compensation, shares"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number, before forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Number of shares issued for compensation"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r296",
                    "r304",
                    "r323"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Number of share options (or share units) exercised during the current period.",
                            "label":  "Number of Shares, Exercised"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodSharesStockOptionsExercised",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity"
                    ],
                "xbrltype":  "sharesItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueIssuedForServices":  {
                "auth_ref":  [
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value of stock issued in lieu of cash for services contributed to the entity.  Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
                            "label":  "Stock issued for future services"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueIssuedForServices",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueNewIssues":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r296",
                    "r304"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Equity impact of the value of new stock issued during the period.  Includes shares issued in an initial public offering or a secondary public offering.",
                            "label":  "Common stock issued as commitment fee for Promissory Note",
                            "verboseLabel":  "Stock issued"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueNewIssues",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation":  {
                "auth_ref":  [
                    "r26",
                    "r27",
                    "r304",
                    "r333"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Value, after forfeiture, of shares issued under share-based payment arrangement.  Excludes employee stock ownership plan (ESOP).",
                            "label":  "Stock based compensation"
                            }
                        }
                    },
                "localname":  "StockIssuedDuringPeriodValueShareBasedCompensation",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquity":  {
                "auth_ref":  [
                    "r27",
                    "r31",
                    "r32",
                    "r109",
                    "r189",
                    "r193",
                    "r406",
                    "r447"
                    ],
                "calculation":  {
                    "http://organicell.com/role/ConsolidatedBalanceSheets":  {
                        "order":  2.0,
                        "parentTag":  "us-gaap_LiabilitiesAndStockholdersEquity",
                        "weight":  1.0
                        }
                    },
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent.  The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest).  This excludes temporary equity and is sometimes called permanent equity.",
                            "label":  "Stockholders' Equity Attributable to Parent",
                            "periodEndLabel":  "Ending balance, value",
                            "periodStartLabel":  "Beginning balance, value",
                            "totalLabel":  "Total Stockholders\u2019 Deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquity",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets",
                    "http://organicell.com/role/ConsolidatedChangesToStockholdersDeficit"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_StockholdersEquityAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Stockholders\u2019 Deficit"
                            }
                        }
                    },
                "localname":  "StockholdersEquityAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedBalanceSheets"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_StockholdersEquityNoteDisclosureTextBlock":  {
                "auth_ref":  [
                    "r107",
                    "r280",
                    "r283",
                    "r284",
                    "r285",
                    "r286",
                    "r287",
                    "r288",
                    "r289",
                    "r290",
                    "r292",
                    "r293",
                    "r295",
                    "r304",
                    "r305",
                    "r398"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income.  Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
                            "label":  "CAPITAL STOCK"
                            }
                        }
                    },
                "localname":  "StockholdersEquityNoteDisclosureTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStock"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventLineItems":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Detail information of subsequent event by type.  User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
                            "label":  "Subsequent Event [Line Items]"
                            }
                        }
                    },
                "localname":  "SubsequentEventLineItems",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventMember":  {
                "auth_ref":  [
                    "r414",
                    "r449"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event [Member]"
                            }
                        }
                    },
                "localname":  "SubsequentEventMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventTable":  {
                "auth_ref":  [
                    "r414",
                    "r449"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
                            "label":  "Subsequent Event [Table]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTable",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeAxis":  {
                "auth_ref":  [
                    "r414",
                    "r449"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
                            "label":  "Subsequent Event Type [Axis]"
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventTypeDomain":  {
                "auth_ref":  [
                    "r414",
                    "r449"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
                            }
                        }
                    },
                "localname":  "SubsequentEventTypeDomain",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/SubsequentEventsDetailsNarrative",
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                },
            "us-gaap_SubsequentEventsAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "Subsequent Events [Abstract]"
                            }
                        }
                    },
                "localname":  "SubsequentEventsAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "xbrltype":  "stringItemType"
                },
            "us-gaap_SubsequentEventsPolicyPolicyTextBlock":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for reporting subsequent events.",
                            "label":  "Subsequent Events"
                            }
                        }
                    },
                "localname":  "SubsequentEventsPolicyPolicyTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubsequentEventsTextBlock":  {
                "auth_ref":  [
                    "r448",
                    "r450"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.  Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
                            "label":  "SUBSEQUENT EVENTS"
                            }
                        }
                    },
                "localname":  "SubsequentEventsTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SubsequentEvents"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock":  {
                "auth_ref":  [
                    "r7"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern.  Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.",
                            "label":  "GOING CONCERN"
                            }
                        }
                    },
                "localname":  "SubstantialDoubtAboutGoingConcernTextBlock",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/GoingConcern"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_SupplementalCashFlowInformationAbstract":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "label":  "SUPPLEMENTAL CASH FLOW INFORMATION:"
                            }
                        }
                    },
                "localname":  "SupplementalCashFlowInformationAbstract",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/ConsolidatedStatementsOfCashFlows"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_TypeOfArrangementAxis":  {
                "auth_ref":  [
                    "r388"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
                            "label":  "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
                            }
                        }
                    },
                "localname":  "TypeOfArrangementAxis",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CapitalStockDetailsNarrative",
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/LeaseObligationsDetailsNarrative",
                    "http://organicell.com/role/NotesPayableDetailsNarrative",
                    "http://organicell.com/role/RelatedPartyTransactionsDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "stringItemType"
                },
            "us-gaap_UseOfEstimates":  {
                "auth_ref":  [
                    "r146",
                    "r147",
                    "r149",
                    "r150",
                    "r153",
                    "r154",
                    "r155"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
                            "label":  "Use of Estimates"
                            }
                        }
                    },
                "localname":  "UseOfEstimates",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
                    ],
                "xbrltype":  "textBlockItemType"
                },
            "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount":  {
                "auth_ref":  [
                    "r366"
                    ],
                "crdr":  "credit",
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
                            "label":  "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
                            "negatedLabel":  "Change in Valuation Allowance"
                            }
                        }
                    },
                "localname":  "ValuationAllowanceDeferredTaxAssetChangeInAmount",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/IncomeTaxesDetails"
                    ],
                "xbrltype":  "monetaryItemType"
                },
            "us-gaap_WarrantExercisePriceIncrease":  {
                "auth_ref":  [
                    "r297"
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Per share increase in exercise price of warrant.  Excludes change due to standard antidilution provision.",
                            "label":  "Exercise Price"
                            }
                        }
                    },
                "localname":  "WarrantExercisePriceIncrease",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "perShareItemType"
                },
            "us-gaap_WarrantMember":  {
                "auth_ref":  [
                    ],
                "lang":  {
                    "en-us":  {
                        "role":  {
                            "documentation":  "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
                            "label":  "Warrant [Member]"
                            }
                        }
                    },
                "localname":  "WarrantMember",
                "nsuri":  "http://fasb.org/us-gaap/2022",
                "presentation":  [
                    "http://organicell.com/role/CommitmentsAndContingenciesDetailsNarrative",
                    "http://organicell.com/role/RestructuringDetailsNarrative",
                    "http://organicell.com/role/WarrantsDetails",
                    "http://organicell.com/role/WarrantsDetails-WarrantActivity",
                    "http://organicell.com/role/WarrantsDetailsNarrative"
                    ],
                "xbrltype":  "domainItemType"
                }
            },
        "unitCount":  5
        }
    },
"std_ref":  {
    "r0":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "105",
        "URI":  "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
        },
    "r1":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
        },
    "r10":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r100":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
        },
    "r101":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
        },
    "r102":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r103":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r104":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
        },
    "r105":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(c))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r106":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(d))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r107":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(e)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r108":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(f))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r109":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(g)(1)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r11":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
        },
    "r110":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(1)(Note 1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r111":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h)(2))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r112":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(h))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r113":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(k)(1))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r114":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(m)(1)(iii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r115":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(m)(2)(ii))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r116":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.4-08(n))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
        },
    "r117":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.12-04(a))",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
        },
    "r118":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "235",
        "URI":  "https://asc.fasb.org/topic&trid=2122369"
        },
    "r119":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "23",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
        },
    "r12":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
        },
    "r120":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
        },
    "r121":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
        },
    "r122":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r123":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(3)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
        },
    "r124":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r125":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
        },
    "r126":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
        },
    "r127":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
        },
    "r128":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
        },
    "r129":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
        },
    "r13":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r130":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "250",
        "URI":  "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
        },
    "r131":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
        },
    "r132":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
        },
    "r133":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "55",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
        },
    "r134":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r135":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "60B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
        },
    "r136":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r137":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
        },
    "r138":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "260",
        "URI":  "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
        },
    "r139":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "270",
        "URI":  "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305"
        },
    "r14":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(13))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r140":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "270",
        "URI":  "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306"
        },
    "r141":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
        },
    "r142":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
        },
    "r143":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
        },
    "r144":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "272",
        "URI":  "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
        },
    "r145":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r146":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r147":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r148":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
        },
    "r149":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
        },
    "r15":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(14))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r150":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
        },
    "r151":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
        },
    "r152":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
        },
    "r153":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
        },
    "r154":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
        },
    "r155":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
        },
    "r156":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "275",
        "URI":  "https://asc.fasb.org/topic&trid=2134479"
        },
    "r157":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
        },
    "r158":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
        },
    "r159":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
        },
    "r16":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(17))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r160":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
        },
    "r161":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r162":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r163":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r164":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r165":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r166":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
        },
    "r167":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "26",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
        },
    "r168":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r169":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r17":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(18))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r170":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r171":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "30",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
        },
    "r172":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "31",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
        },
    "r173":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r174":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r175":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r176":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r177":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r178":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "32",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
        },
    "r179":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "34",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
        },
    "r18":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19)(a)(5))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r180":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
        },
    "r181":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r182":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "41",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
        },
    "r183":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "42",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
        },
    "r184":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "280",
        "URI":  "https://asc.fasb.org/topic&trid=2134510"
        },
    "r185":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
        },
    "r186":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
        },
    "r187":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
        },
    "r188":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
        },
    "r189":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 4.E)",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
        },
    "r19":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(19))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r190":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
        },
    "r191":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
        },
    "r192":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "310",
        "URI":  "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
        },
    "r193":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "323",
        "URI":  "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
        },
    "r194":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
        },
    "r195":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
        },
    "r196":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "326",
        "URI":  "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922903-210455"
        },
    "r197":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
        },
    "r198":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
        },
    "r199":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
        },
    "r2":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
        },
    "r20":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(20))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r200":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 5.BB)",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
        },
    "r201":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.BB)",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
        },
    "r202":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "330",
        "URI":  "https://asc.fasb.org/topic&trid=2126998"
        },
    "r203":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "05",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316"
        },
    "r204":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "340",
        "URI":  "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
        },
    "r205":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)(2)",
        "Topic":  "350",
        "URI":  "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
        },
    "r206":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228"
        },
    "r207":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r208":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r209":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r21":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(21))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r210":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
        },
    "r211":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
        },
    "r212":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "360",
        "URI":  "https://asc.fasb.org/topic&trid=2155823"
        },
    "r213":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "410",
        "URI":  "https://asc.fasb.org/extlink&oid=6392692&loc=d3e7535-110849"
        },
    "r214":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "410",
        "URI":  "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
        },
    "r215":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r216":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)(2)",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r217":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
        },
    "r218":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 5.P.4(e))",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
        },
    "r219":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "420",
        "URI":  "https://asc.fasb.org/topic&trid=2175745"
        },
    "r22":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(22))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r220":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r221":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
        },
    "r222":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "440",
        "URI":  "https://asc.fasb.org/topic&trid=2144648"
        },
    "r223":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
        },
    "r224":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
        },
    "r225":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q2)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r226":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "20",
        "Subparagraph":  "(SAB Topic 5.Y.Q4)",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
        },
    "r227":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "450",
        "URI":  "https://asc.fasb.org/topic&trid=2127136"
        },
    "r228":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
        },
    "r229":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r23":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(26)(c))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r230":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(ii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r231":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r232":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r233":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iii))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r234":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r235":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-01(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
        },
    "r236":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(i))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r237":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(A))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r238":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(B))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r239":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iii)(C))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r24":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r240":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(4)(iv))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r241":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.13-02(a)(5))",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
        },
    "r242":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r243":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r244":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r245":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r246":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r247":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(f)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r248":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r249":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(h)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r25":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(27))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r250":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(i)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r251":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
        },
    "r252":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r253":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r254":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
        },
    "r255":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r256":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r257":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1D",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
        },
    "r258":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r259":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r26":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(28))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r260":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r261":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1E",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
        },
    "r262":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r263":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r264":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r265":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1F",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
        },
    "r266":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r267":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r268":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1I",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
        },
    "r269":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
        },
    "r27":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(29))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r270":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69B",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
        },
    "r271":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69C",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
        },
    "r272":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69E",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
        },
    "r273":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "69F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
        },
    "r274":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "470",
        "URI":  "https://asc.fasb.org/topic&trid=2208564"
        },
    "r275":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "10",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
        },
    "r276":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(CFRR 211.02)",
        "Topic":  "480",
        "URI":  "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
        },
    "r277":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
        },
    "r278":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
        },
    "r279":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r28":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(3)(a)(2))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r280":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r281":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r282":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r283":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r284":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r285":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(i)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r286":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
        },
    "r287":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r288":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r289":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
        },
    "r29":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r290":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
        },
    "r291":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
        },
    "r292":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r293":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r294":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r295":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "18",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
        },
    "r296":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
        },
    "r297":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
        },
    "r298":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
        },
    "r299":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
        },
    "r3":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(e)",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
        },
    "r30":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30)(a)(3))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r300":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
        },
    "r301":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
        },
    "r302":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
        },
    "r303":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
        },
    "r304":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.3-04)",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
        },
    "r305":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "505",
        "URI":  "https://asc.fasb.org/topic&trid=2208762"
        },
    "r306":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
        },
    "r307":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "91",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "606",
        "URI":  "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
        },
    "r308":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(5)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r309":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(d)(i)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r31":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(30))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r310":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(n)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
        },
    "r311":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "80",
        "Subparagraph":  "(d)",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
        },
    "r312":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "80",
        "Topic":  "715",
        "URI":  "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
        },
    "r313":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "30",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898"
        },
    "r314":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r315":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r316":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r317":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r318":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r319":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r32":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(31))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r320":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r321":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r322":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r323":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r324":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r325":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(1)(iv)(04)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r326":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r327":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r328":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r329":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r33":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(32))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r330":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(01)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r331":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(02)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r332":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)(2)(iii)(03)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r333":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r334":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r335":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r336":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(e)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r337":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r338":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r339":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r34":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r340":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r341":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(ii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r342":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iii)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r343":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(iv)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r344":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)(v)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r345":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r346":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(h)(1)(i)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r347":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
        },
    "r348":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r349":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(1)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r35":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r350":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(f)(2)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
        },
    "r351":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 14.D.2.Q6)",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
        },
    "r352":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "35",
        "SubTopic":  "30",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911"
        },
    "r353":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "718",
        "URI":  "https://asc.fasb.org/topic&trid=2228938"
        },
    "r354":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "730",
        "URI":  "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
        },
    "r355":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
        },
    "r356":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
        },
    "r357":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
        },
    "r358":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
        },
    "r359":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
        },
    "r36":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r360":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
        },
    "r361":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
        },
    "r362":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
        },
    "r363":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "19",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
        },
    "r364":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r365":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r366":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
        },
    "r367":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
        },
    "r368":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
        },
    "r369":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
        },
    "r37":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6)(c))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r370":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
        },
    "r371":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
        },
    "r372":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r373":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r374":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "9",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
        },
    "r375":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r376":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(d)(3)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
        },
    "r377":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.5.Q1)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r378":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB TOPIC 6.I.7)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r379":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.7)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r38":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(6))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r380":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.1)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r381":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.2)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r382":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 6.I.Fact.4)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
        },
    "r383":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.C)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
        },
    "r384":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
        },
    "r385":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "270",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
        },
    "r386":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
        },
    "r387":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "740",
        "URI":  "https://asc.fasb.org/topic&trid=2144680"
        },
    "r388":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "808",
        "URI":  "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
        },
    "r389":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r39":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(7))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r390":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
        },
    "r391":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bb)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r392":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "810",
        "URI":  "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
        },
    "r393":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
        },
    "r394":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
        },
    "r395":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
        },
    "r396":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
        },
    "r397":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
        },
    "r398":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(a)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
        },
    "r399":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)(3)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r4":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5C",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)(2)",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
        },
    "r40":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02(9))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r400":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)",
        "Topic":  "815",
        "URI":  "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
        },
    "r401":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(bbb)(2)",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
        },
    "r402":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "60",
        "SubTopic":  "10",
        "Topic":  "820",
        "URI":  "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
        },
    "r403":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
        },
    "r404":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
        },
    "r405":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
        },
    "r406":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "825",
        "URI":  "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
        },
    "r407":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "230",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
        },
    "r408":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
        },
    "r409":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(a)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r41":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(a))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r410":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(b)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r411":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(c)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r412":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Subparagraph":  "(d)",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
        },
    "r413":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
        },
    "r414":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "830",
        "URI":  "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
        },
    "r415":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
        },
    "r416":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
        },
    "r417":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
        },
    "r418":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
        },
    "r419":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "30",
        "Topic":  "835",
        "URI":  "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
        },
    "r42":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19(b),22(b))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r420":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "40",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Subparagraph":  "(Note 3)",
        "Topic":  "840",
        "URI":  "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
        },
    "r421":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "840",
        "URI":  "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717"
        },
    "r422":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(a)",
        "Topic":  "840",
        "URI":  "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
        },
    "r423":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Topic":  "840",
        "URI":  "https://asc.fasb.org/extlink&oid=123416376&loc=d3e50796-112755"
        },
    "r424":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
        },
    "r425":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(b)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
        },
    "r426":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "20",
        "Subparagraph":  "(c)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
        },
    "r427":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
        },
    "r428":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(1)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r429":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(g)(3)",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r43":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r430":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
        },
    "r431":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
        },
    "r432":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "53",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
        },
    "r433":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/subtopic&trid=77888251"
        },
    "r434":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "30",
        "Topic":  "842",
        "URI":  "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981"
        },
    "r435":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "10",
        "Subparagraph":  "(a)(3)(iii)(03)",
        "Topic":  "848",
        "URI":  "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
        },
    "r436":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r437":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r438":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r439":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r44":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19,20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r440":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
        },
    "r441":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
        },
    "r442":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
        },
    "r443":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
        },
    "r444":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "850",
        "URI":  "https://asc.fasb.org/topic&trid=2122745"
        },
    "r445":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r446":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
        },
    "r447":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "10",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "10",
        "Topic":  "852",
        "URI":  "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
        },
    "r448":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r449":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
        },
    "r45":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.19-26)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r450":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "Topic":  "855",
        "URI":  "https://asc.fasb.org/topic&trid=2122774"
        },
    "r451":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r452":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r453":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(c)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
        },
    "r454":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(1)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r455":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(2)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r456":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Subparagraph":  "(b)(3)",
        "Topic":  "860",
        "URI":  "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
        },
    "r457":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "910",
        "URI":  "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
        },
    "r458":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "11",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406"
        },
    "r459":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "330",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
        },
    "r46":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.20)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r460":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "730",
        "Topic":  "912",
        "URI":  "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
        },
    "r461":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SAB Topic 11.L)",
        "Topic":  "924",
        "URI":  "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
        },
    "r462":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r463":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
        },
    "r464":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r465":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
        },
    "r466":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r467":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
        },
    "r468":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r469":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "33",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
        },
    "r47":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.21)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r470":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(a)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r471":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "35A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(b)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
        },
    "r472":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(1)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r473":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "8",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "235",
        "Subparagraph":  "(c)(2)",
        "Topic":  "932",
        "URI":  "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
        },
    "r474":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "25",
        "SubTopic":  "20",
        "Topic":  "940",
        "URI":  "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
        },
    "r475":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(10))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r476":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(11))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r477":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(13))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r478":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(16))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r479":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03(23))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r48":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(1))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r480":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.10(3))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r481":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.9-03.17)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
        },
    "r482":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(15))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r483":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04(22))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r484":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.9-04.9)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
        },
    "r485":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "235",
        "Subparagraph":  "(SX 210.9-05(b)(2))",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
        },
    "r486":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
        },
    "r487":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "470",
        "Subparagraph":  "(c)",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
        },
    "r488":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "942",
        "URI":  "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
        },
    "r489":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(16))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r49":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22(a)(2))",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r490":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(10))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r491":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(12))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r492":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(16))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r493":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(23)(a)(4))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r494":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(25))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r495":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03(a)(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r496":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.(a),19)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r497":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.1(h))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r498":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.7-03.3)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
        },
    "r499":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(18))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r5":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
        },
    "r50":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.22)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r500":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(8))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r501":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.7-04(9))",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
        },
    "r502":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7A",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "40",
        "Subparagraph":  "(d)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
        },
    "r503":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13H",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Subparagraph":  "(c)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
        },
    "r504":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "29F",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "40",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
        },
    "r505":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(e)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r506":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(1)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r507":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(f)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r508":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(g)(2)(i)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r509":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "65",
        "SubTopic":  "40",
        "Subparagraph":  "(h)(2)",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
        },
    "r51":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.25)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r510":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "825",
        "Topic":  "944",
        "URI":  "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
        },
    "r511":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "20",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
        },
    "r512":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "210",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
        },
    "r513":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "210",
        "Subparagraph":  "(SX 210.6-04(12)(b)(3))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
        },
    "r514":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "220",
        "Subparagraph":  "(k)",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268"
        },
    "r515":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.6-07.1(c))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
        },
    "r516":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "220",
        "Subparagraph":  "(SX 210.6-07.2(a),(b),(c),(d))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
        },
    "r517":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r518":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r519":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column B)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r52":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r520":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r521":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r522":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column C)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r523":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 1))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r524":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 6))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r525":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-12B(Column D)(Footnote 7))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
        },
    "r526":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5D",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-13D(Column B)(Footnote 2))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
        },
    "r527":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5D",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-13D(Column C)(Footnote 2))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
        },
    "r528":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column A))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r529":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column B))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r53":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-02.29-31)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
        },
    "r530":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column C))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r531":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "320",
        "Subparagraph":  "(SX 210.12-15(Column D))",
        "Topic":  "946",
        "URI":  "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
        },
    "r532":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
        },
    "r533":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "440",
        "Subparagraph":  "(a)",
        "Topic":  "954",
        "URI":  "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
        },
    "r534":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Subparagraph":  "(d)",
        "Topic":  "958",
        "URI":  "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
        },
    "r535":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
        },
    "r536":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "7",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "360",
        "Topic":  "958",
        "URI":  "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
        },
    "r537":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(c)",
        "Topic":  "976",
        "URI":  "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
        },
    "r538":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "310",
        "Subparagraph":  "(b)",
        "Topic":  "978",
        "URI":  "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
        },
    "r539":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "810",
        "Subparagraph":  "(SAB Topic 10.A)",
        "Topic":  "980",
        "URI":  "https://asc.fasb.org/extlink&oid=116722093&loc=d3e661063-123039"
        },
    "r54":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "16",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
        },
    "r540":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "20",
        "Topic":  "985",
        "URI":  "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
        },
    "r541":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12"
        },
    "r542":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b"
        },
    "r543":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-2"
        },
    "r544":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "b-23"
        },
    "r545":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "d1-1"
        },
    "r546":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12",
        "Subsection":  "g"
        },
    "r547":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "12, 13, 15d"
        },
    "r548":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13e",
        "Subsection":  "4c"
        },
    "r549":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14d",
        "Subsection":  "2b"
        },
    "r55":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "21",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
        },
    "r550":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "15",
        "Subsection":  "d"
        },
    "r551":  {
        "Name":  "Exchange Act",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "14a",
        "Subsection":  "12"
        },
    "r552":  {
        "Name":  "Form 10-K",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "310"
        },
    "r553":  {
        "Name":  "Form 10-Q",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "308",
        "Subsection":  "a"
        },
    "r554":  {
        "Name":  "Form 20-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "220",
        "Subsection":  "f"
        },
    "r555":  {
        "Name":  "Form 40-F",
        "Number":  "249",
        "Publisher":  "SEC",
        "Section":  "240",
        "Subsection":  "f"
        },
    "r556":  {
        "Name":  "Forms 10-K, 10-Q, 20-F",
        "Number":  "240",
        "Publisher":  "SEC",
        "Section":  "13",
        "Subsection":  "a-1"
        },
    "r557":  {
        "Name":  "Regulation S-K (SK)",
        "Number":  "229",
        "Paragraph":  "(a)",
        "Publisher":  "SEC",
        "Section":  "1402"
        },
    "r558":  {
        "Name":  "Regulation S-T",
        "Number":  "232",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r559":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "405"
        },
    "r56":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "22",
        "Publisher":  "FASB",
        "Section":  "55",
        "SubTopic":  "20",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
        },
    "r560":  {
        "Name":  "Securities Act",
        "Number":  "230",
        "Publisher":  "SEC",
        "Section":  "425"
        },
    "r561":  {
        "Name":  "Securities Act",
        "Number":  "7A",
        "Publisher":  "SEC",
        "Section":  "B",
        "Subsection":  "2"
        },
    "r57":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1A",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
        },
    "r58":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1B",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
        },
    "r59":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
        },
    "r6":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "20",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/subtopic&trid=2122178"
        },
    "r60":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
        },
    "r61":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
        },
    "r62":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "6",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
        },
    "r63":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(210.5-03(11))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r64":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(1))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r65":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(10))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r66":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(20))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r67":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(4))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r68":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(5))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r69":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03(8))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r7":  {
        "Name":  "Accounting Standards Codification",
        "Publisher":  "FASB",
        "SubTopic":  "40",
        "Topic":  "205",
        "URI":  "https://asc.fasb.org/subtopic&trid=51888271"
        },
    "r70":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.1(e))",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r71":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.1,2)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r72":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.2)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r73":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.3)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r74":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.4)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r75":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.8)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r76":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "S99",
        "SubTopic":  "10",
        "Subparagraph":  "(SX 210.5-03.9)",
        "Topic":  "220",
        "URI":  "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
        },
    "r77":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
        },
    "r78":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "12",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
        },
    "r79":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r8":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r80":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "13",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(c)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
        },
    "r81":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r82":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r83":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "14",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
        },
    "r84":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "15",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
        },
    "r85":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "17",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(d)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
        },
    "r86":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "24",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
        },
    "r87":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(e)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r88":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(f)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r89":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r9":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(g)",
        "Topic":  "210",
        "URI":  "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
        },
    "r90":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "25",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
        },
    "r91":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(a)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r92":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Subparagraph":  "(b)",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r93":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "28",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
        },
    "r94":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "45",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
        },
    "r95":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "1",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
        },
    "r96":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "2",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
        },
    "r97":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "3",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
        },
    "r98":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "4",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
        },
    "r99":  {
        "Name":  "Accounting Standards Codification",
        "Paragraph":  "5",
        "Publisher":  "FASB",
        "Section":  "50",
        "SubTopic":  "10",
        "Topic":  "230",
        "URI":  "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
        }
    },
"version":  "2.1"
}


22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/06/22  Organicell Regenerative Medi… Inc 8-K:1,9     9/01/22   12:532K                                   Empire Filings/FA
 8/23/22  Organicell Regenerative Medi… Inc 8-K:1,3,5,9 8/19/22   26:4.7M                                   Empire Filings/FA
 2/14/22  Organicell Regenerative Medi… Inc 10-K       10/31/21   74:8.2M                                   Empire Filings/FA
11/02/21  Organicell Regenerative Medi… Inc 8-K:1,3,9  10/29/21   11:211K                                   Empire Filings/FA
11/01/21  Organicell Regenerative Medi… Inc S-8        11/01/21    4:215K                                   Empire Filings/FA
 2/08/21  Organicell Regenerative Medi… Inc 10-K       10/31/20   71:5.1M                                   Empire Filings/FA
10/16/20  Organicell Regenerative Medi… Inc 10-K       10/31/19   81:6.5M                                   GlobalOne Filings Inc/FA
 7/14/20  Organicell Regenerative Medi… Inc 8-K:3,5     6/24/20    2:136K                                   GlobalOne Filings Inc/FA
 4/30/20  Organicell Regenerative Medi… Inc 8-K:1,3,5,9 3/30/20    2:87K                                    GlobalOne Filings Inc/FA
11/01/18  Organicell Regenerative Medi… Inc 10-K       10/31/17   83:6.4M                                   GlobalOne Filings Inc/FA
 4/26/18  Organicell Regenerative Medi… Inc 8-K:1,3,5,8 4/23/18    3:195K                                   M2 Compliance LLC/FA
 4/12/18  Organicell Regenerative Medi… Inc 8-K:1,5,9   4/06/18    5:248K                                   M2 Compliance LLC/FA
 2/09/18  Organicell Regenerative Medi… Inc 8-K:1,2,3,5 2/05/18    3:608K                                   M2 Compliance LLC/FA
12/18/17  Organicell Regenerative Medi… Inc 8-K:5,9    12/13/17    2:345K                                   M2 Compliance LLC/FA
 7/07/17  Organicell Regenerative Medi… Inc 10-K       10/31/16   68:5.6M                                   M2 Compliance LLC/FA
 5/23/17  Organicell Regenerative Medi… Inc 8-K:1,3,8,9 5/17/17    3:631K                                   M2 Compliance LLC/FA
 4/03/17  Organicell Regenerative Medi… Inc 8-K:1,2,3,9 3/29/17    6:678K                                   Discount Edgar/FA
 3/15/17  Organicell Regenerative Medi… Inc 8-K:1,3,5,8 3/08/17   11:604K                                   Discount Edgar/FA
11/14/16  Organicell Regenerative Medi… Inc 8-K:3,5,9  11/04/16    8:618K                                   Discount Edgar/FA
11/03/16  Organicell Regenerative Medi… Inc 8-K:1,3,8,911/01/16    5:129K                                   Discount Edgar/FA
11/03/15  Organicell Regenerative Medi… Inc 8-K:2,3,5,910/30/15    3:926K                                   Discount Edgar/FA
 9/04/12  Organicell Regenerative Medi… Inc S-1                    5:913K                                   Clark Corp Law Group LLP
Top
Filing Submission 0001829126-22-017082   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 6, 1:21:26.5pm ET